{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T14:44:37Z","timestamp":1794926677589,"version":"4.9.1"},"reference-count":254,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,3,26]],"date-time":"2021-03-26T00:00:00Z","timestamp":1616716800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,3,26]],"date-time":"2021-03-26T00:00:00Z","timestamp":1616716800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Rete Cardiologica of the Italian Ministry of Health"},{"DOI":"10.13039\/501100001711","name":"Schweizerischer Nationalfonds zur F\u00f6rderung der Wissenschaftlichen Forschung","doi-asserted-by":"publisher","award":["310030_197510"],"award-info":[{"award-number":["310030_197510"]}],"id":[{"id":"10.13039\/501100001711","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Alfred and Annemarie von Sick Grants for Translational and Clinical Research Cardiology and Oncology"},{"DOI":"10.13039\/501100004362","name":"Schweizerische Herzstiftung","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004362","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Sheikh Khalifa's Foundation"},{"DOI":"10.13039\/501100006447","name":"Universit\u00e4t Z\u00fcrich","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100006447","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Basic Res Cardiol"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Despite major advances in prevention and treatment, cardiac and cerebral atherothrombotic complications still account for substantial morbidity and mortality worldwide. In this context, inflammation is involved in the chronic process leading atherosclerotic plaque formation and its complications, as well as in the maladaptive response to acute ischemic events. For this reason, modulation of inflammation is nowadays seen as a promising therapeutic strategy to counteract the burden of cardio- and cerebrovascular disease. Being produced and recognized by both inflammatory and vascular cells, the complex network of cytokines holds key functions in the crosstalk of these two systems and orchestrates the progression of atherothrombosis. By binding to membrane receptors, these soluble mediators trigger specific intracellular signaling pathways eventually leading to the activation of transcription factors and a deep modulation of cell function. Both stimulatory and inhibitory cytokines have been described and progressively reported as markers of disease or interesting therapeutic targets in the cardiovascular field. Nevertheless, cytokine inhibition is burdened by harmful side effects that will most likely prevent its chronic use in favor of acute administrations in well-selected subjects at high risk. Here, we summarize the current state of knowledge regarding the modulatory role of cytokines on atherosclerosis, myocardial infarction, and stroke. Then, we discuss evidence from clinical trials specifically targeting cytokines and the potential implication of these advances into daily clinical practice.<\/jats:p>","DOI":"10.1007\/s00395-021-00863-x","type":"journal-article","created":{"date-parts":[[2021,3,26]],"date-time":"2021-03-26T05:21:20Z","timestamp":1616736080000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":96,"title":["Cytokines as therapeutic targets for cardio- and cerebrovascular diseases"],"prefix":"10.1007","volume":"116","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1472-7975","authenticated-orcid":false,"given":"Luca","family":"Liberale","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Ministrini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federico","family":"Carbone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni G.","family":"Camici","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabrizio","family":"Montecucco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,3,26]]},"reference":[{"key":"863_CR1","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1016\/j.amjcard.2014.11.003","volume":"115","author":"A Abbate","year":"2015","unstructured":"Abbate A, Kontos MC, Abouzaki NA, Melchior RD, Thomas C, Van Tassell BW, Oddi C, Carbone S, Trankle CR, Roberts CS, Mueller GH, Gambill ML, Christopher S, Markley R, Vetrovec GW, Dinarello CA, Biondi-Zoccai G (2015) Comparative safety of interleukin-1 blockade with anakinra in patients with ST-segment elevation acute myocardial infarction (from the VCU-ART and VCU-ART2 pilot studies). Am J Cardiol 115:288\u2013292. https:\/\/doi.org\/10.1016\/j.amjcard.2014.11.003","journal-title":"Am J Cardiol"},{"key":"863_CR2","doi-asserted-by":"publisher","first-page":"e27923","DOI":"10.1371\/journal.pone.0027923","volume":"6","author":"A Abbate","year":"2011","unstructured":"Abbate A, Salloum FN, Van Tassell BW, Vecile E, Toldo S, Seropian I, Mezzaroma E, Dobrina A (2011) Alterations in the interleukin-1\/interleukin-1 receptor antagonist balance modulate cardiac remodeling following myocardial infarction in the mouse. PLoS ONE 6:e27923. https:\/\/doi.org\/10.1371\/journal.pone.0027923","journal-title":"PLoS ONE"},{"key":"863_CR3","doi-asserted-by":"publisher","first-page":"2670","DOI":"10.1161\/CIRCULATIONAHA.107.740233","volume":"117","author":"A Abbate","year":"2008","unstructured":"Abbate A, Salloum FN, Vecile E, Das A, Hoke NN, Straino S, Biondi-Zoccai GG, Houser JE, Qureshi IZ, Ownby ED, Gustini E, Biasucci LM, Severino A, Capogrossi MC, Vetrovec GW, Crea F, Baldi A, Kukreja RC, Dobrina A (2008) Anakinra, a recombinant human interleukin-1 receptor antagonist, inhibits apoptosis in experimental acute myocardial infarction. Circulation 117:2670\u20132683. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.107.740233","journal-title":"Circulation"},{"key":"863_CR4","doi-asserted-by":"publisher","first-page":"e014941","DOI":"10.1161\/JAHA.119.014941","volume":"9","author":"A Abbate","year":"2020","unstructured":"Abbate A, Trankle CR, Buckley LF, Lipinski MJ, Appleton D, Kadariya D, Canada JM, Carbone S, Roberts CS, Abouzaki N, Melchior R, Christopher S, Turlington J, Mueller G, Garnett J, Thomas C, Markley R, Wohlford GF, Puckett L, Medina de Chazal H, Chiabrando JG, Bressi E, Del Buono MG, Schatz A, Vo C, Dixon DL, Biondi-Zoccai GG, Kontos MC, Van Tassell BW (2020) Interleukin-1 blockade inhibits the acute inflammatory response in patients with ST-segment-elevation myocardial infarction. J Am Heart Assoc 9:e014941. https:\/\/doi.org\/10.1161\/JAHA.119.014941","journal-title":"J Am Heart Assoc"},{"key":"863_CR5","doi-asserted-by":"publisher","first-page":"1394","DOI":"10.1016\/j.amjcard.2013.01.287","volume":"111","author":"A Abbate","year":"2013","unstructured":"Abbate A, Van Tassell BW, Biondi-Zoccai G, Kontos MC, Grizzard JD, Spillman DW, Oddi C, Roberts CS, Melchior RD, Mueller GH, Abouzaki NA, Rengel LR, Varma A, Gambill ML, Falcao RA, Voelkel NF, Dinarello CA, Vetrovec GW (2013) Effects of interleukin-1 blockade with anakinra on adverse cardiac remodeling and heart failure after acute myocardial infarction [from the Virginia Commonwealth University-Anakinra Remodeling Trial (2) (VCU-ART2) pilot study]. Am J Cardiol 111:1394\u20131400. https:\/\/doi.org\/10.1016\/j.amjcard.2013.01.287","journal-title":"Am J Cardiol"},{"key":"863_CR6","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/s1074-7613(04)00046-9","volume":"20","author":"L Agostini","year":"2004","unstructured":"Agostini L, Martinon F, Burns K, McDermott MF, Hawkins PN, Tschopp J (2004) NALP3 forms an IL-1beta-processing inflammasome with increased activity in Muckle-Wells autoinflammatory disorder. Immunity 20:319\u2013325. https:\/\/doi.org\/10.1016\/s1074-7613(04)00046-9","journal-title":"Immunity"},{"key":"863_CR7","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1080\/09629359990298","volume":"8","author":"P Akarasereenont","year":"1999","unstructured":"Akarasereenont P, Techatrisak K, Chotewuttakorn S, Thaworn A (1999) The induction of cyclooxygenase-2 in IL-1beta-treated endothelial cells is inhibited by prostaglandin E2 through cAMP. Mediators Inflamm 8:287\u2013294. https:\/\/doi.org\/10.1080\/09629359990298","journal-title":"Mediators Inflamm"},{"key":"863_CR8","doi-asserted-by":"publisher","first-page":"317ra196","DOI":"10.1126\/scitranslmed.aad5330","volume":"7","author":"JE Alard","year":"2015","unstructured":"Alard JE, Ortega-Gomez A, Wichapong K, Bongiovanni D, Horckmans M, Megens RT, Leoni G, Ferraro B, Rossaint J, Paulin N, Ng J, Ippel H, Suylen D, Hinkel R, Blanchet X, Gaillard F, D\u2019Amico M, von Hundelshausen P, Zarbock A, Scheiermann C, Hackeng TM, Steffens S, Kupatt C, Nicolaes GA, Weber C, Soehnlein O (2015) Recruitment of classical monocytes can be inhibited by disturbing heteromers of neutrophil HNP1 and platelet CCL5. Sci Transl Med 7:317ra196. https:\/\/doi.org\/10.1126\/scitranslmed.aad5330","journal-title":"Sci Transl Med"},{"key":"863_CR9","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1172\/JCI43713","volume":"122","author":"MR Alexander","year":"2012","unstructured":"Alexander MR, Moehle CW, Johnson JL, Yang Z, Lee JK, Jackson CL, Owens GK (2012) Genetic inactivation of IL-1 signaling enhances atherosclerotic plaque instability and reduces outward vessel remodeling in advanced atherosclerosis in mice. J Clin Invest 122:70\u201379. https:\/\/doi.org\/10.1172\/JCI43713","journal-title":"J Clin Invest"},{"key":"863_CR10","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1038\/s41586-020-2403-9","volume":"583","author":"C Amor","year":"2020","unstructured":"Amor C, Feucht J, Leibold J, Ho YJ, Zhu C, Alonso-Curbelo D, Mansilla-Soto J, Boyer JA, Li X, Giavridis T, Kulick A, Houlihan S, Peerschke E, Friedman SL, Ponomarev V, Piersigilli A, Sadelain M, Lowe SW (2020) Senolytic CAR T cells reverse senescence-associated pathologies. Nature 583:127\u2013132. https:\/\/doi.org\/10.1038\/s41586-020-2403-9","journal-title":"Nature"},{"key":"863_CR11","doi-asserted-by":"publisher","first-page":"L1232","DOI":"10.1152\/ajplung.00109.2006","volume":"291","author":"DJ Angelini","year":"2006","unstructured":"Angelini DJ, Hyun SW, Grigoryev DN, Garg P, Gong P, Singh IS, Passaniti A, Hasday JD, Goldblum SE (2006) TNF-alpha increases tyrosine phosphorylation of vascular endothelial cadherin and opens the paracellular pathway through fyn activation in human lung endothelia. Am J Physiol Lung Cell Mol Physiol 291:L1232-1245. https:\/\/doi.org\/10.1152\/ajplung.00109.2006","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"863_CR12","doi-asserted-by":"publisher","first-page":"e001108","DOI":"10.1136\/openhrt-2019-001108","volume":"6","author":"AK Anstensrud","year":"2019","unstructured":"Anstensrud AK, Woxholt S, Sharma K, Broch K, Bendz B, Aakhus S, Ueland T, Amundsen BH, Damas JK, Hopp E, Kleveland O, Stensaeth KH, Opdahl A, Klow NE, Seljeflot I, Andersen GO, Wiseth R, Aukrust P, Gullestad L (2019) Rationale for the ASSAIL-MI-trial: a randomised controlled trial designed to assess the effect of tocilizumab on myocardial salvage in patients with acute ST-elevation myocardial infarction (STEMI). Open Heart 6:e001108. https:\/\/doi.org\/10.1136\/openhrt-2019-001108","journal-title":"Open Heart"},{"key":"863_CR13","doi-asserted-by":"publisher","first-page":"936","DOI":"10.3109\/00207454.2014.980906","volume":"125","author":"CA Arango-Davila","year":"2015","unstructured":"Arango-Davila CA, Vera A, Londono AC, Echeverri AF, Canas F, Cardozo CF, Orozco JL, Rengifo J, Canas CA (2015) Soluble or soluble\/membrane TNF-alpha inhibitors protect the brain from focal ischemic injury in rats. Int J Neurosci 125:936\u2013940. https:\/\/doi.org\/10.3109\/00207454.2014.980906","journal-title":"Int J Neurosci"},{"key":"863_CR14","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/1475-2840-12-12","volume":"12","author":"T Baars","year":"2013","unstructured":"Baars T, Konorza T, Kahlert P, Mohlenkamp S, Erbel R, Heusch G, Kleinbongard P (2013) Coronary aspirate TNFalpha reflects saphenous vein bypass graft restenosis risk in diabetic patients. Cardiovasc Diabetol 12:12. https:\/\/doi.org\/10.1186\/1475-2840-12-12","journal-title":"Cardiovasc Diabetol"},{"key":"863_CR15","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1007\/112_2020_26","volume":"177","author":"A Bahrami","year":"2020","unstructured":"Bahrami A, Liberale L, Reiner Z, Carbone F, Montecucco F, Sahebkar A (2020) Inflammatory biomarkers for cardiovascular risk stratification in familial hypercholesterolemia. Rev Physiol Biochem Pharmacol 177:25\u201352. https:\/\/doi.org\/10.1007\/112_2020_26","journal-title":"Rev Physiol Biochem Pharmacol"},{"key":"863_CR16","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1161\/01.str.28.6.1233","volume":"28","author":"FC Barone","year":"1997","unstructured":"Barone FC, Arvin B, White RF, Miller A, Webb CL, Willette RN, Lysko PG, Feuerstein GZ (1997) Tumor necrosis factor-alpha. A mediator of focal ischemic brain injury. Stroke 28:1233\u20131244. https:\/\/doi.org\/10.1161\/01.str.28.6.1233","journal-title":"Stroke"},{"key":"863_CR17","doi-asserted-by":"publisher","first-page":"H927","DOI":"10.1152\/ajpheart.00374.2002","volume":"284","author":"S Belosjorow","year":"2003","unstructured":"Belosjorow S, Bolle I, Duschin A, Heusch G, Schulz R (2003) TNF-alpha antibodies are as effective as ischemic preconditioning in reducing infarct size in rabbits. Am J Physiol Heart Circ Physiol 284:H927-930. https:\/\/doi.org\/10.1152\/ajpheart.00374.2002","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"863_CR18","doi-asserted-by":"publisher","first-page":"2674","DOI":"10.4049\/jimmunol.166.4.2674","volume":"166","author":"DJ Berg","year":"2001","unstructured":"Berg DJ, Zhang J, Lauricella DM, Moore SA (2001) Il-10 is a central regulator of cyclooxygenase-2 expression and prostaglandin production. J Immunol 166:2674\u20132680. https:\/\/doi.org\/10.4049\/jimmunol.166.4.2674","journal-title":"J Immunol"},{"key":"863_CR19","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1016\/j.bbrc.2009.05.046","volume":"385","author":"N Bergh","year":"2009","unstructured":"Bergh N, Ulfhammer E, Glise K, Jern S, Karlsson L (2009) Influence of TNF-alpha and biomechanical stress on endothelial anti- and prothrombotic genes. Biochem Biophys Res Commun 385:314\u2013318. https:\/\/doi.org\/10.1016\/j.bbrc.2009.05.046","journal-title":"Biochem Biophys Res Commun"},{"key":"863_CR20","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1016\/j.healun.2004.06.021","volume":"23","author":"MF Berry","year":"2004","unstructured":"Berry MF, Woo YJ, Pirolli TJ, Bish LT, Moise MA, Burdick JW, Morine KJ, Jayasankar V, Gardner TJ, Sweeney HL (2004) Administration of a tumor necrosis factor inhibitor at the time of myocardial infarction attenuates subsequent ventricular remodeling. J Heart Lung Transplant 23:1061\u20131068. https:\/\/doi.org\/10.1016\/j.healun.2004.06.021","journal-title":"J Heart Lung Transplant"},{"key":"863_CR21","doi-asserted-by":"publisher","first-page":"H340","DOI":"10.1152\/ajpheart.01210.2003","volume":"287","author":"C Berthonneche","year":"2004","unstructured":"Berthonneche C, Sulpice T, Boucher F, Gouraud L, de Leiris J, O\u2019Connor SE, Herbert JM, Janiak P (2004) New insights into the pathological role of TNF-alpha in early cardiac dysfunction and subsequent heart failure after infarction in rats. Am J Physiol Heart Circ Physiol 287:H340-350. https:\/\/doi.org\/10.1152\/ajpheart.01210.2003","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"863_CR22","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1084\/jem.160.2.618","volume":"160","author":"MP Bevilacqua","year":"1984","unstructured":"Bevilacqua MP, Pober JS, Majeau GR, Cotran RS, Gimbrone MA Jr (1984) Interleukin 1 (IL-1) induces biosynthesis and cell surface expression of procoagulant activity in human vascular endothelial cells. J Exp Med 160:618\u2013623. https:\/\/doi.org\/10.1084\/jem.160.2.618","journal-title":"J Exp Med"},{"key":"863_CR23","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1161\/CIRCRESAHA.119.315185","volume":"126","author":"C Boada","year":"2020","unstructured":"Boada C, Zinger A, Tsao C, Zhao P, Martinez JO, Hartman K, Naoi T, Sukhoveshin R, Sushnitha M, Molinaro R, Trachtenberg B, Cooke JP, Tasciotti E (2020) Rapamycin-loaded biomimetic nanoparticles reverse vascular inflammation. Circ Res 126:25\u201337. https:\/\/doi.org\/10.1161\/CIRCRESAHA.119.315185","journal-title":"Circ Res"},{"key":"863_CR24","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.cardiores.2005.01.001","volume":"66","author":"LS Boesten","year":"2005","unstructured":"Boesten LS, Zadelaar AS, van Nieuwkoop A, Gijbels MJ, de Winther MP, Havekes LM, van Vlijmen BJ (2005) Tumor necrosis factor-alpha promotes atherosclerotic lesion progression in APOE*3-Leiden transgenic mice. Cardiovasc Res 66:179\u2013185. https:\/\/doi.org\/10.1016\/j.cardiores.2005.01.001","journal-title":"Cardiovasc Res"},{"key":"863_CR25","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1160\/TH17-09-0630","volume":"118","author":"A Bonaventura","year":"2018","unstructured":"Bonaventura A, Liberale L, Carbone F, Vecchie A, Diaz-Canestro C, Camici GG, Montecucco F, Dallegri F (2018) The pathophysiological role of neutrophil extracellular traps in inflammatory diseases. Thromb Haemost 118:6\u201327. https:\/\/doi.org\/10.1160\/TH17-09-0630","journal-title":"Thromb Haemost"},{"key":"863_CR26","doi-asserted-by":"publisher","first-page":"2173","DOI":"10.1038\/s41598-019-38670-z","volume":"9","author":"NR Bonetti","year":"2019","unstructured":"Bonetti NR, Diaz-Canestro C, Liberale L, Crucet M, Akhmedov A, Merlini M, Reiner MF, Gobbato S, Stivala S, Kollias G, Ruschitzka F, Luscher TF, Beer JH, Camici GG (2019) Tumour necrosis factor-alpha inhibition improves stroke outcome in a mouse model of rheumatoid arthritis. Sci Rep 9:2173. https:\/\/doi.org\/10.1038\/s41598-019-38670-z","journal-title":"Sci Rep"},{"key":"863_CR27","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1111\/j.1600-065X.2008.00714.x","volume":"226","author":"K Boniface","year":"2008","unstructured":"Boniface K, Blom B, Liu YJ, de Waal MR (2008) From interleukin-23 to T-helper 17 cells: human T-helper cell differentiation revisited. Immunol Rev 226:132\u2013146. https:\/\/doi.org\/10.1111\/j.1600-065X.2008.00714.x","journal-title":"Immunol Rev"},{"key":"863_CR28","doi-asserted-by":"publisher","first-page":"5528","DOI":"10.1523\/JNEUROSCI.21-15-05528.2001","volume":"21","author":"H Boutin","year":"2001","unstructured":"Boutin H, LeFeuvre RA, Horai R, Asano M, Iwakura Y, Rothwell NJ (2001) Role of IL-1alpha and IL-1beta in ischemic brain damage. J Neurosci 21:5528\u20135534","journal-title":"J Neurosci"},{"key":"863_CR29","doi-asserted-by":"publisher","first-page":"2137","DOI":"10.1161\/01.ATV.0000143933.20616.1b","volume":"24","author":"L Branen","year":"2004","unstructured":"Branen L, Hovgaard L, Nitulescu M, Bengtsson E, Nilsson J, Jovinge S (2004) Inhibition of tumor necrosis factor-alpha reduces atherosclerosis in apolipoprotein E knockout mice. Arterioscler Thromb Vasc Biol 24:2137\u20132142. https:\/\/doi.org\/10.1161\/01.ATV.0000143933.20616.1b","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"863_CR30","doi-asserted-by":"publisher","first-page":"5489","DOI":"10.4049\/jimmunol.1001623","volume":"186","author":"GT Brown","year":"2011","unstructured":"Brown GT, McIntyre TM (2011) Lipopolysaccharide signaling without a nucleus: kinase cascades stimulate platelet shedding of proinflammatory IL-1beta-rich microparticles. J Immunol 186:5489\u20135496. https:\/\/doi.org\/10.4049\/jimmunol.1001623","journal-title":"J Immunol"},{"key":"863_CR31","doi-asserted-by":"publisher","first-page":"57","DOI":"10.2353\/ajpath.2008.070974","volume":"173","author":"M Bujak","year":"2008","unstructured":"Bujak M, Dobaczewski M, Chatila K, Mendoza LH, Li N, Reddy A, Frangogiannis NG (2008) Interleukin-1 receptor type I signaling critically regulates infarct healing and cardiac remodeling. Am J Pathol 173:57\u201367. https:\/\/doi.org\/10.2353\/ajpath.2008.070974","journal-title":"Am J Pathol"},{"key":"863_CR32","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1161\/CIRCRESAHA.108.178475","volume":"103","author":"JS Burchfield","year":"2008","unstructured":"Burchfield JS, Iwasaki M, Koyanagi M, Urbich C, Rosenthal N, Zeiher AM, Dimmeler S (2008) Interleukin-10 from transplanted bone marrow mononuclear cells contributes to cardiac protection after myocardial infarction. Circ Res 103:203\u2013211. https:\/\/doi.org\/10.1161\/CIRCRESAHA.108.178475","journal-title":"Circ Res"},{"key":"863_CR33","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1189\/jlb.70.2.192","volume":"70","author":"MJ Burne","year":"2001","unstructured":"Burne MJ, Elghandour A, Haq M, Saba SR, Norman J, Condon T, Bennett F, Rabb H (2001) IL-1 and TNF independent pathways mediate ICAM-1\/VCAM-1 up-regulation in ischemia reperfusion injury. J Leukoc Biol 70:192\u2013198","journal-title":"J Leukoc Biol"},{"key":"863_CR34","doi-asserted-by":"publisher","first-page":"1621","DOI":"10.1093\/eurheartj\/ehx239","volume":"38","author":"GG Camici","year":"2017","unstructured":"Camici GG, Liberale L (2017) Aging: the next cardiovascular disease? Eur Heart J 38:1621\u20131623. https:\/\/doi.org\/10.1093\/eurheartj\/ehx239","journal-title":"Eur Heart J"},{"key":"863_CR35","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1002\/path.2305","volume":"214","author":"M Canault","year":"2008","unstructured":"Canault M, Peiretti F, Poggi M, Mueller C, Kopp F, Bonardo B, Bastelica D, Nicolay A, Alessi MC, Nalbone G (2008) Progression of atherosclerosis in ApoE-deficient mice that express distinct molecular forms of TNF-alpha. J Pathol 214:574\u2013583. https:\/\/doi.org\/10.1002\/path.2305","journal-title":"J Pathol"},{"key":"863_CR36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s12016-018-8714-z","volume":"58","author":"F Carbone","year":"2020","unstructured":"Carbone F, Bonaventura A, Liberale L, Paolino S, Torre F, Dallegri F, Montecucco F, Cutolo M (2020) Atherosclerosis in rheumatoid arthritis: promoters and opponents. Clin Rev Allergy Immunol 58:1\u201314. https:\/\/doi.org\/10.1007\/s12016-018-8714-z","journal-title":"Clin Rev Allergy Immunol"},{"key":"863_CR37","doi-asserted-by":"publisher","first-page":"5662","DOI":"10.2174\/1381612822666160822124546","volume":"22","author":"F Carbone","year":"2016","unstructured":"Carbone F, Liberale L, Bonaventura A, Cea M, Montecucco F (2016) Targeting inflammation in primary cardiovascular prevention. Curr Pharm Des 22:5662\u20135675. https:\/\/doi.org\/10.2174\/1381612822666160822124546","journal-title":"Curr Pharm Des"},{"key":"863_CR38","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.vph.2016.08.004","volume":"85","author":"F Carbone","year":"2016","unstructured":"Carbone F, Satta N, Burger F, Roth A, Lenglet S, Pagano S, Lescuyer P, Bertolotto M, Spinella G, Pane B, Palombo D, Pende A, Dallegri F, Mach F, Vuilleumier N, Montecucco F (2016) Vitamin D receptor is expressed within human carotid plaques and correlates with pro-inflammatory M1 macrophages. Vascul Pharmacol 85:57\u201365. https:\/\/doi.org\/10.1016\/j.vph.2016.08.004","journal-title":"Vascul Pharmacol"},{"key":"863_CR39","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1007\/s00296-017-3842-y","volume":"38","author":"MB Carroll","year":"2018","unstructured":"Carroll MB, Haller C, Smith C (2018) Short-term application of tocilizumab during myocardial infarction (STAT-MI). Rheumatol Int 38:59\u201366. https:\/\/doi.org\/10.1007\/s00296-017-3842-y","journal-title":"Rheumatol Int"},{"key":"863_CR40","doi-asserted-by":"publisher","first-page":"1654","DOI":"10.2337\/dc11-2219","volume":"35","author":"C Cavelti-Weder","year":"2012","unstructured":"Cavelti-Weder C, Babians-Brunner A, Keller C, Stahel MA, Kurz-Levin M, Zayed H, Solinger AM, Mandrup-Poulsen T, Dinarello CA, Donath MY (2012) Effects of gevokizumab on glycemia and inflammatory markers in type 2 diabetes. Diabetes Care 35:1654\u20131662. https:\/\/doi.org\/10.2337\/dc11-2219","journal-title":"Diabetes Care"},{"key":"863_CR41","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1038\/s41419-019-1716-9","volume":"10","author":"AQ Chen","year":"2019","unstructured":"Chen AQ, Fang Z, Chen XL, Yang S, Zhou YF, Mao L, Xia YP, Jin HJ, Li YN, You MF, Wang XX, Lei H, He QW, Hu B (2019) Microglia-derived TNF-alpha mediates endothelial necroptosis aggravating blood brain-barrier disruption after ischemic stroke. Cell Death Dis 10:487. https:\/\/doi.org\/10.1038\/s41419-019-1716-9","journal-title":"Cell Death Dis"},{"key":"863_CR42","doi-asserted-by":"publisher","first-page":"245","DOI":"10.2174\/157340208786241336","volume":"4","author":"X Chen","year":"2008","unstructured":"Chen X, Andresen BT, Hill M, Zhang J, Booth F, Zhang C (2008) Role of reactive oxygen species in tumor necrosis factor-alpha induced endothelial dysfunction. Curr Hypertens Rev 4:245\u2013255. https:\/\/doi.org\/10.2174\/157340208786241336","journal-title":"Curr Hypertens Rev"},{"key":"863_CR43","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1089\/107999001750169871","volume":"21","author":"L Chi","year":"2001","unstructured":"Chi L, Li Y, Stehno-Bittel L, Gao J, Morrison DC, Stechschulte DJ, Dileepan KN (2001) Interleukin-6 production by endothelial cells via stimulation of protease-activated receptors is amplified by endotoxin and tumor necrosis factor-alpha. J Interferon Cytokine Res 21:231\u2013240. https:\/\/doi.org\/10.1089\/107999001750169871","journal-title":"J Interferon Cytokine Res"},{"key":"863_CR44","doi-asserted-by":"publisher","first-page":"14812","DOI":"10.1074\/jbc.RA118.004220","volume":"293","author":"S Choi","year":"2018","unstructured":"Choi S, Park M, Kim J, Park W, Kim S, Lee DK, Hwang JY, Choe J, Won MH, Ryoo S, Ha KS, Kwon YG, Kim YM (2018) TNF-alpha elicits phenotypic and functional alterations of vascular smooth muscle cells by miR-155-5p-dependent down-regulation of cGMP-dependent kinase 1. J Biol Chem 293:14812\u201314822. https:\/\/doi.org\/10.1074\/jbc.RA118.004220","journal-title":"J Biol Chem"},{"key":"863_CR45","doi-asserted-by":"publisher","first-page":"3133","DOI":"10.1161\/01.CIR.0000077913.60364.D2","volume":"107","author":"ES Chung","year":"2003","unstructured":"Chung ES, Packer M, Lo KH, Fasanmade AA, Willerson JT, Anti TNFTACHFI (2003) Randomized, double-blind, placebo-controlled, pilot trial of infliximab, a chimeric monoclonal antibody to tumor necrosis factor-alpha, in patients with moderate-to-severe heart failure: results of the anti-TNF Therapy Against Congestive Heart Failure (ATTACH) trial. Circulation 107:3133\u20133140. https:\/\/doi.org\/10.1161\/01.CIR.0000077913.60364.D2","journal-title":"Circulation"},{"key":"863_CR46","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1038\/sj.jcbfm.9600537","volume":"28","author":"SR Clark","year":"2008","unstructured":"Clark SR, McMahon CJ, Gueorguieva I, Rowland M, Scarth S, Georgiou R, Tyrrell PJ, Hopkins SJ, Rothwell NJ (2008) Interleukin-1 receptor antagonist penetrates human brain at experimentally therapeutic concentrations. J Cereb Blood Flow Metab 28:387\u2013394. https:\/\/doi.org\/10.1038\/sj.jcbfm.9600537","journal-title":"J Cereb Blood Flow Metab"},{"key":"863_CR47","doi-asserted-by":"publisher","first-page":"1715","DOI":"10.1161\/01.str.31.7.1715","volume":"31","author":"WM Clark","year":"2000","unstructured":"Clark WM, Rinker LG, Lessov NS, Hazel K, Hill JK, Stenzel-Poore M, Eckenstein F (2000) Lack of interleukin-6 expression is not protective against focal central nervous system ischemia. Stroke 31:1715\u20131720. https:\/\/doi.org\/10.1161\/01.str.31.7.1715","journal-title":"Stroke"},{"key":"863_CR48","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1186\/s12974-014-0203-6","volume":"11","author":"BH Clausen","year":"2014","unstructured":"Clausen BH, Degn M, Martin NA, Couch Y, Karimi L, Ormhoj M, Mortensen ML, Gredal HB, Gardiner C, Sargent II, Szymkowski DE, Petit GH, Deierborg T, Finsen B, Anthony DC, Lambertsen KL (2014) Systemically administered anti-TNF therapy ameliorates functional outcomes after focal cerebral ischemia. J Neuroinflammation 11:203. https:\/\/doi.org\/10.1186\/s12974-014-0203-6","journal-title":"J Neuroinflammation"},{"key":"863_CR49","doi-asserted-by":"publisher","first-page":"29291","DOI":"10.1038\/srep29291","volume":"6","author":"BH Clausen","year":"2016","unstructured":"Clausen BH, Degn M, Sivasaravanaparan M, Fogtmann T, Andersen MG, Trojanowsky MD, Gao H, Hvidsten S, Baun C, Deierborg T, Finsen B, Kristensen BW, Bak ST, Meyer M, Lee J, Nedospasov SA, Brambilla R, Lambertsen KL (2016) Conditional ablation of myeloid TNF increases lesion volume after experimental stroke in mice, possibly via altered ERK1\/2 signaling. Sci Rep 6:29291. https:\/\/doi.org\/10.1038\/srep29291","journal-title":"Sci Rep"},{"key":"863_CR50","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/1742-2094-5-46","volume":"5","author":"BH Clausen","year":"2008","unstructured":"Clausen BH, Lambertsen KL, Babcock AA, Holm TH, Dagnaes-Hansen F, Finsen B (2008) Interleukin-1beta and tumor necrosis factor-alpha are expressed by different subsets of microglia and macrophages after ischemic stroke in mice. J Neuroinflammation 5:46. https:\/\/doi.org\/10.1186\/1742-2094-5-46","journal-title":"J Neuroinflammation"},{"key":"863_CR51","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1007\/s00401-016-1541-5","volume":"131","author":"BH Clausen","year":"2016","unstructured":"Clausen BH, Lambertsen KL, Dagnaes-Hansen F, Babcock AA, von Linstow CU, Meldgaard M, Kristensen BW, Deierborg T, Finsen B (2016) Cell therapy centered on IL-1Ra is neuroprotective in experimental stroke. Acta Neuropathol 131:775\u2013791. https:\/\/doi.org\/10.1007\/s00401-016-1541-5","journal-title":"Acta Neuropathol"},{"key":"863_CR52","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1016\/s1388-9842(02)00121-6","volume":"4","author":"AP Coletta","year":"2002","unstructured":"Coletta AP, Clark AL, Banarjee P, Cleland JG (2002) Clinical trials update: RENEWAL (RENAISSANCE and RECOVER) and ATTACH. Eur J Heart Fail 4:559\u2013561. https:\/\/doi.org\/10.1016\/s1388-9842(02)00121-6","journal-title":"Eur J Heart Fail"},{"key":"863_CR53","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1038\/mi.2016.47","volume":"10","author":"SM Coomes","year":"2017","unstructured":"Coomes SM, Kannan Y, Pelly VS, Entwistle LJ, Guidi R, Perez-Lloret J, Nikolov N, M\u00fcller W, Wilson MS (2017) CD4(+) Th2 cells are directly regulated by IL-10 during allergic airway inflammation. Mucosal Immunol 10:150\u2013161. https:\/\/doi.org\/10.1038\/mi.2016.47","journal-title":"Mucosal Immunol"},{"key":"863_CR54","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1161\/ATVBAHA.111.229997","volume":"32","author":"K Danzaki","year":"2012","unstructured":"Danzaki K, Matsui Y, Ikesue M, Ohta D, Ito K, Kanayama M, Kurotaki D, Morimoto J, Iwakura Y, Yagita H, Tsutsui H, Uede T (2012) Interleukin-17A deficiency accelerates unstable atherosclerotic plaque formation in apolipoprotein E-deficient mice. Arterioscler Thromb Vasc Biol 32:273\u2013280. https:\/\/doi.org\/10.1161\/ATVBAHA.111.229997","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"863_CR55","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1016\/S0002-9440(10)63471-2","volume":"163","author":"P Davenport","year":"2003","unstructured":"Davenport P, Tipping PG (2003) The role of interleukin-4 and interleukin-12 in the progression of atherosclerosis in apolipoprotein E-deficient mice. Am J Pathol 163:1117\u20131125. https:\/\/doi.org\/10.1016\/S0002-9440(10)63471-2","journal-title":"Am J Pathol"},{"key":"863_CR56","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1097\/00004647-199901000-00010","volume":"19","author":"CA Davies","year":"1999","unstructured":"Davies CA, Loddick SA, Toulmond S, Stroemer RP, Hunt J, Rothwell NJ (1999) The progression and topographic distribution of interleukin-1beta expression after permanent middle cerebral artery occlusion in the rat. J Cereb Blood Flow Metab 19:87\u201398. https:\/\/doi.org\/10.1097\/00004647-199901000-00010","journal-title":"J Cereb Blood Flow Metab"},{"key":"863_CR57","doi-asserted-by":"publisher","first-page":"109","DOI":"10.4161\/cc.11.1.18473","volume":"11","author":"R Davis","year":"2012","unstructured":"Davis R, Pillai S, Lawrence N, Sebti S, Chellappan SP (2012) TNF-alpha-mediated proliferation of vascular smooth muscle cells involves Raf-1-mediated inactivation of Rb and transcription of E2F1-regulated genes. Cell Cycle 11:109\u2013118. https:\/\/doi.org\/10.4161\/cc.11.1.18473","journal-title":"Cell Cycle"},{"key":"863_CR58","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.yjmcc.2004.03.012","volume":"37","author":"B Dawn","year":"2004","unstructured":"Dawn B, Guo Y, Rezazadeh A, Wang OL, Stein AB, Hunt G, Varma J, Xuan YT, Wu WJ, Tan W, Zhu X, Bolli R (2004) Tumor necrosis factor-alpha does not modulate ischemia\/reperfusion injury in naive myocardium but is essential for the development of late preconditioning. J Mol Cell Cardiol 37:51\u201361. https:\/\/doi.org\/10.1016\/j.yjmcc.2004.03.012","journal-title":"J Mol Cell Cardiol"},{"key":"863_CR59","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1111\/j.1471-4159.2009.06098.x","volume":"110","author":"F de Bilbao","year":"2009","unstructured":"de Bilbao F, Arsenijevic D, Moll T, Garcia-Gabay I, Vallet P, Langhans W, Giannakopoulos P (2009) In vivo over-expression of interleukin-10 increases resistance to focal brain ischemia in mice. J Neurochem 110:12\u201322. https:\/\/doi.org\/10.1111\/j.1471-4159.2009.06098.x","journal-title":"J Neurochem"},{"key":"863_CR60","doi-asserted-by":"publisher","first-page":"C209","DOI":"10.1152\/ajpcell.00157.2006","volume":"292","author":"J Dong","year":"2007","unstructured":"Dong J, Fujii S, Imagawa S, Matsumoto S, Matsushita M, Todo S, Tsutsui H, Sobel BE (2007) IL-1 and IL-6 induce hepatocyte plasminogen activator inhibitor-1 expression through independent signaling pathways converging on C\/EBPdelta. Am J Physiol Cell Physiol 292:C209-215. https:\/\/doi.org\/10.1152\/ajpcell.00157.2006","journal-title":"Am J Physiol Cell Physiol"},{"key":"863_CR61","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1161\/ATVBAHA.107.159327","volume":"28","author":"AC Doran","year":"2008","unstructured":"Doran AC, Meller N, McNamara CA (2008) Role of smooth muscle cells in the initiation and early progression of atherosclerosis. Arterioscler Thromb Vasc Biol 28:812\u2013819. https:\/\/doi.org\/10.1161\/ATVBAHA.107.159327","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"863_CR62","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1038\/nature11260","volume":"487","author":"P Dutta","year":"2012","unstructured":"Dutta P, Courties G, Wei Y, Leuschner F, Gorbatov R, Robbins CS, Iwamoto Y, Thompson B, Carlson AL, Heidt T, Majmudar MD, Lasitschka F, Etzrodt M, Waterman P, Waring MT, Chicoine AT, van der Laan AM, Niessen HW, Piek JJ, Rubin BB, Butany J, Stone JR, Katus HA, Murphy SA, Morrow DA, Sabatine MS, Vinegoni C, Moskowitz MA, Pittet MJ, Libby P, Lin CP, Swirski FK, Weissleder R, Nahrendorf M (2012) Myocardial infarction accelerates atherosclerosis. Nature 487:325\u2013329. https:\/\/doi.org\/10.1038\/nature11260","journal-title":"Nature"},{"key":"863_CR63","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1161\/01.cir.97.3.242","volume":"97","author":"R Elhage","year":"1998","unstructured":"Elhage R, Maret A, Pieraggi MT, Thiers JC, Arnal JF, Bayard F (1998) Differential effects of interleukin-1 receptor antagonist and tumor necrosis factor binding protein on fatty-streak formation in apolipoprotein E-deficient mice. Circulation 97:242\u2013244. https:\/\/doi.org\/10.1161\/01.cir.97.3.242","journal-title":"Circulation"},{"key":"863_CR64","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.1038\/nm.2513","volume":"17","author":"H Ellingsgaard","year":"2011","unstructured":"Ellingsgaard H, Hauselmann I, Schuler B, Habib AM, Baggio LL, Meier DT, Eppler E, Bouzakri K, Wueest S, Muller YD, Hansen AM, Reinecke M, Konrad D, Gassmann M, Reimann F, Halban PA, Gromada J, Drucker DJ, Gribble FM, Ehses JA, Donath MY (2011) Interleukin-6 enhances insulin secretion by increasing glucagon-like peptide-1 secretion from L cells and alpha cells. Nat Med 17:1481\u20131489. https:\/\/doi.org\/10.1038\/nm.2513","journal-title":"Nat Med"},{"key":"863_CR65","doi-asserted-by":"publisher","first-page":"1681","DOI":"10.1002\/art.1780361206","volume":"36","author":"MJ Elliott","year":"1993","unstructured":"Elliott MJ, Maini RN, Feldmann M, Long-Fox A, Charles P, Katsikis P, Brennan FM, Walker J, Bijl H, Ghrayeb J et al (1993) Treatment of rheumatoid arthritis with chimeric monoclonal antibodies to tumor necrosis factor alpha. Arthritis Rheum 36:1681\u20131690. https:\/\/doi.org\/10.1002\/art.1780361206","journal-title":"Arthritis Rheum"},{"key":"863_CR66","doi-asserted-by":"publisher","first-page":"1366","DOI":"10.1136\/jnnp.2004.054882","volume":"76","author":"HC Emsley","year":"2005","unstructured":"Emsley HC, Smith CJ, Georgiou RF, Vail A, Hopkins SJ, Rothwell NJ, Tyrrell PJ, Acute Stroke I (2005) A randomised phase II study of interleukin-1 receptor antagonist in acute stroke patients. J Neurol Neurosurg Psychiatry 76:1366\u20131372. https:\/\/doi.org\/10.1136\/jnnp.2004.054882","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"863_CR67","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.117.008257","author":"D Engelbertsen","year":"2018","unstructured":"Engelbertsen D, Depuydt MAC, Verwilligen RAF, Rattik S, Levinsohn E, Edsfeldt A, Kuperwaser F, Jarolim P, Lichtman AH (2018) IL-23R deficiency does not impact atherosclerotic plaque development in mice. J Am Heart Assoc. https:\/\/doi.org\/10.1161\/JAHA.117.008257","journal-title":"J Am Heart Assoc"},{"key":"863_CR68","doi-asserted-by":"publisher","first-page":"8167","DOI":"10.4049\/jimmunol.0901126","volume":"183","author":"C Erbel","year":"2009","unstructured":"Erbel C, Chen L, Bea F, Wangler S, Celik S, Lasitschka F, Wang Y, Bockler D, Katus HA, Dengler TJ (2009) Inhibition of IL-17A attenuates atherosclerotic lesion development in apoE-deficient mice. J Immunol 183:8167\u20138175. https:\/\/doi.org\/10.4049\/jimmunol.0901126","journal-title":"J Immunol"},{"key":"863_CR69","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.7150\/ijbs.4679","volume":"8","author":"M Erta","year":"2012","unstructured":"Erta M, Quintana A, Hidalgo J (2012) Interleukin-6, a major cytokine in the central nervous system. Int J Biol Sci 8:1254\u20131266. https:\/\/doi.org\/10.7150\/ijbs.4679","journal-title":"Int J Biol Sci"},{"key":"863_CR70","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1161\/CIRCULATIONAHA.118.038010","volume":"139","author":"BM Everett","year":"2019","unstructured":"Everett BM, Cornel JH, Lainscak M, Anker SD, Abbate A, Thuren T, Libby P, Glynn RJ, Ridker PM (2019) Anti-inflammatory therapy with canakinumab for the prevention of hospitalization for heart failure. Circulation 139:1289\u20131299. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.118.038010","journal-title":"Circulation"},{"issue":"943\u2013957","key":"863_CR71","doi-asserted-by":"publisher","first-page":"e949","DOI":"10.1016\/j.immuni.2018.09.011","volume":"49","author":"AR Fatkhullina","year":"2018","unstructured":"Fatkhullina AR, Peshkova IO, Dzutsev A, Aghayev T, McCulloch JA, Thovarai V, Badger JH, Vats R, Sundd P, Tang HY, Kossenkov AV, Hazen SL, Trinchieri G, Grivennikov SI, Koltsova EK (2018) An interleukin-23-interleukin-22 axis regulates intestinal microbial homeostasis to protect from diet-induced atherosclerosis. Immunity 49(943\u2013957):e949. https:\/\/doi.org\/10.1016\/j.immuni.2018.09.011","journal-title":"Immunity"},{"key":"863_CR72","doi-asserted-by":"publisher","first-page":"1695","DOI":"10.3892\/etm.2015.2363","volume":"9","author":"Q Feng","year":"2015","unstructured":"Feng Q, Wang YI, Yang Y (2015) Neuroprotective effect of interleukin-6 in a rat model of cerebral ischemia. Exp Ther Med 9:1695\u20131701. https:\/\/doi.org\/10.3892\/etm.2015.2363","journal-title":"Exp Ther Med"},{"key":"863_CR73","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1016\/j.yjmcc.2008.08.014","volume":"45","author":"MP Flaherty","year":"2008","unstructured":"Flaherty MP, Guo Y, Tiwari S, Rezazadeh A, Hunt G, Sanganalmath SK, Tang XL, Bolli R, Dawn B (2008) The role of TNF-alpha receptors p55 and p75 in acute myocardial ischemia\/reperfusion injury and late preconditioning. J Mol Cell Cardiol 45:735\u2013741. https:\/\/doi.org\/10.1016\/j.yjmcc.2008.08.014","journal-title":"J Mol Cell Cardiol"},{"key":"863_CR74","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1084\/jem.185.5.933","volume":"185","author":"RM Friedlander","year":"1997","unstructured":"Friedlander RM, Gagliardini V, Hara H, Fink KB, Li W, MacDonald G, Fishman MC, Greenberg AH, Moskowitz MA, Yuan J (1997) Expression of a dominant negative mutant of interleukin-1 beta converting enzyme in transgenic mice prevents neuronal cell death induced by trophic factor withdrawal and ischemic brain injury. J Exp Med 185:933\u2013940. https:\/\/doi.org\/10.1084\/jem.185.5.933","journal-title":"J Exp Med"},{"key":"863_CR75","doi-asserted-by":"publisher","first-page":"2118","DOI":"10.1096\/fj.03-0331fje","volume":"17","author":"M Fuchs","year":"2003","unstructured":"Fuchs M, Hilfiker A, Kaminski K, Hilfiker-Kleiner D, Guener Z, Klein G, Podewski E, Schieffer B, Rose-John S, Drexler H (2003) Role of interleukin-6 for LV remodeling and survival after experimental myocardial infarction. FASEB J 17:2118\u20132120. https:\/\/doi.org\/10.1096\/fj.03-0331fje","journal-title":"FASEB J"},{"key":"863_CR76","doi-asserted-by":"publisher","first-page":"2622","DOI":"10.1038\/s41467-020-16439-7","volume":"11","author":"C Gao","year":"2020","unstructured":"Gao C, Huang Q, Liu C, Kwong CHT, Yue L, Wan JB, Lee SMY, Wang R (2020) Treatment of atherosclerosis by macrophage-biomimetic nanoparticles via targeted pharmacotherapy and sequestration of proinflammatory cytokines. Nat Commun 11:2622. https:\/\/doi.org\/10.1038\/s41467-020-16439-7","journal-title":"Nat Commun"},{"key":"863_CR77","doi-asserted-by":"publisher","first-page":"H1583","DOI":"10.1152\/ajpheart.00346.2014","volume":"308","author":"C Gao","year":"2015","unstructured":"Gao C, Liu Y, Yu Q, Yang Q, Li B, Sun L, Yan W, Cai X, Gao E, Xiong L, Wang H, Tao L (2015) TNF-alpha antagonism ameliorates myocardial ischemia-reperfusion injury in mice by upregulating adiponectin. Am J Physiol Heart Circ Physiol 308:H1583-1591. https:\/\/doi.org\/10.1152\/ajpheart.00346.2014","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"863_CR78","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1007\/s00395-019-0739-9","volume":"114","author":"XM Gao","year":"2019","unstructured":"Gao XM, Su Y, Moore S, Han LP, Kiriazis H, Lu Q, Zhao WB, Ruze A, Fang BB, Duan MJ, Du XJ (2019) Relaxin mitigates microvascular damage and inflammation following cardiac ischemia-reperfusion. Basic Res Cardiol 114:30. https:\/\/doi.org\/10.1007\/s00395-019-0739-9","journal-title":"Basic Res Cardiol"},{"key":"863_CR79","first-page":"1477","volume":"147","author":"JH Garcia","year":"1995","unstructured":"Garcia JH, Liu KF, Relton JK (1995) Interleukin-1 receptor antagonist decreases the number of necrotic neurons in rats with middle cerebral artery occlusion. Am J Pathol 147:1477\u20131486","journal-title":"Am J Pathol"},{"key":"863_CR80","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1161\/CIRCRESAHA.113.301934","volume":"113","author":"S Ge","year":"2013","unstructured":"Ge S, Hertel B, Koltsova EK, Sorensen-Zender I, Kielstein JT, Ley K, Haller H, von Vietinghoff S (2013) Increased atherosclerotic lesion formation and vascular leukocyte accumulation in renal impairment are mediated by interleukin-17A. Circ Res 113:965\u2013974. https:\/\/doi.org\/10.1161\/CIRCRESAHA.113.301934","journal-title":"Circ Res"},{"key":"863_CR81","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1007\/s00395-008-0757-5","volume":"104","author":"C Gebhard","year":"2009","unstructured":"Gebhard C, Stampfli SF, Gebhard CE, Akhmedov A, Breitenstein A, Camici GG, Holy EW, Luscher TF, Tanner FC (2009) Guggulsterone, an anti-inflammatory phytosterol, inhibits tissue factor and arterial thrombosis. Basic Res Cardiol 104:285\u2013294. https:\/\/doi.org\/10.1007\/s00395-008-0757-5","journal-title":"Basic Res Cardiol"},{"key":"863_CR82","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1159\/000111367","volume":"15","author":"HA Gelbard","year":"1993","unstructured":"Gelbard HA, Dzenko KA, DiLoreto D, del Cerro C, del Cerro M, Epstein LG (1993) Neurotoxic effects of tumor necrosis factor alpha in primary human neuronal cultures are mediated by activation of the glutamate AMPA receptor subtype: implications for AIDS neuropathogenesis. Dev Neurosci 15:417\u2013422. https:\/\/doi.org\/10.1159\/000111367","journal-title":"Dev Neurosci"},{"key":"863_CR83","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21176009","author":"V Gelfo","year":"2020","unstructured":"Gelfo V, Romaniello D, Mazzeschi M, Sgarzi M, Grilli G, Morselli A, Manzan B, Rihawi K, Lauriola M (2020) Roles of IL-1 in cancer: from tumor progression to resistance to targeted therapies. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms21176009","journal-title":"Int J Mol Sci"},{"key":"863_CR84","doi-asserted-by":"publisher","first-page":"1964","DOI":"10.1093\/brain\/aws075","volume":"135","author":"K Gertz","year":"2012","unstructured":"Gertz K, Kronenberg G, Kalin RE, Baldinger T, Werner C, Balkaya M, Eom GD, Hellmann-Regen J, Krober J, Miller KR, Lindauer U, Laufs U, Dirnagl U, Heppner FL, Endres M (2012) Essential role of interleukin-6 in post-stroke angiogenesis. Brain 135:1964\u20131980. https:\/\/doi.org\/10.1093\/brain\/aws075","journal-title":"Brain"},{"key":"863_CR85","doi-asserted-by":"publisher","first-page":"196ra100","DOI":"10.1126\/scitranslmed.3006133","volume":"5","author":"A Gistera","year":"2013","unstructured":"Gistera A, Robertson AK, Andersson J, Ketelhuth DF, Ovchinnikova O, Nilsson SK, Lundberg AM, Li MO, Flavell RA, Hansson GK (2013) Transforming growth factor-beta signaling in T cells promotes stabilization of atherosclerotic plaques through an interleukin-17-dependent pathway. Sci Transl Med 5:196ra100. https:\/\/doi.org\/10.1126\/scitranslmed.3006133","journal-title":"Sci Transl Med"},{"key":"863_CR86","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1161\/01.hyp.33.1.183","volume":"33","author":"S Goetze","year":"1999","unstructured":"Goetze S, Xi XP, Kawano Y, Kawano H, Fleck E, Hsueh WA, Law RE (1999) TNF-alpha-induced migration of vascular smooth muscle cells is MAPK dependent. Hypertension 33:183\u2013189. https:\/\/doi.org\/10.1161\/01.hyp.33.1.183","journal-title":"Hypertension"},{"key":"863_CR87","doi-asserted-by":"publisher","first-page":"C894","DOI":"10.1152\/ajpcell.1993.264.4.C894","volume":"264","author":"SE Goldblum","year":"1993","unstructured":"Goldblum SE, Ding X, Campbell-Washington J (1993) TNF-alpha induces endothelial cell F-actin depolymerization, new actin synthesis, and barrier dysfunction. Am J Physiol 264:C894-905. https:\/\/doi.org\/10.1152\/ajpcell.1993.264.4.C894","journal-title":"Am J Physiol"},{"key":"863_CR88","doi-asserted-by":"publisher","first-page":"L57","DOI":"10.1152\/ajplung.1990.258.2.L57","volume":"258","author":"SE Goldblum","year":"1990","unstructured":"Goldblum SE, Sun WL (1990) Tumor necrosis factor-alpha augments pulmonary arterial transendothelial albumin flux in vitro. Am J Physiol 258:L57-67. https:\/\/doi.org\/10.1152\/ajplung.1990.258.2.L57","journal-title":"Am J Physiol"},{"key":"863_CR89","doi-asserted-by":"publisher","DOI":"10.3390\/biom9090416","author":"AM Gorabi","year":"2019","unstructured":"Gorabi AM, Kiaie N, Reiner Z, Carbone F, Montecucco F, Sahebkar A (2019) The therapeutic potential of nanoparticles to reduce inflammation in atherosclerosis. Biomolecules. https:\/\/doi.org\/10.3390\/biom9090416","journal-title":"Biomolecules"},{"key":"863_CR90","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1161\/01.atv.21.5.825","volume":"21","author":"T Grewal","year":"2001","unstructured":"Grewal T, Priceputu E, Davignon J, Bernier L (2001) Identification of a gamma-interferon-responsive element in the promoter of the human macrophage scavenger receptor A gene. Arterioscler Thromb Vasc Biol 21:825\u2013831. https:\/\/doi.org\/10.1161\/01.atv.21.5.825","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"863_CR91","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1016\/j.bbi.2017.05.019","volume":"65","author":"MH Gronhoj","year":"2017","unstructured":"Gronhoj MH, Clausen BH, Fenger CD, Lambertsen KL, Finsen B (2017) Beneficial potential of intravenously administered IL-6 in improving outcome after murine experimental stroke. Brain Behav Immun 65:296\u2013311. https:\/\/doi.org\/10.1016\/j.bbi.2017.05.019","journal-title":"Brain Behav Immun"},{"key":"863_CR92","doi-asserted-by":"publisher","first-page":"737585","DOI":"10.1100\/2012\/737585","volume":"2012","author":"C Grothusen","year":"2012","unstructured":"Grothusen C, Hagemann A, Attmann T, Braesen J, Broch O, Cremer J, Schoettler J (2012) Impact of an interleukin-1 receptor antagonist and erythropoietin on experimental myocardial ischemia\/reperfusion injury. Sci World J 2012:737585. https:\/\/doi.org\/10.1100\/2012\/737585","journal-title":"Sci World J"},{"key":"863_CR93","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1097\/01.fjc.0000250079.46526.38","volume":"48","author":"Q Gu","year":"2006","unstructured":"Gu Q, Yang XP, Bonde P, DiPaula A, Fox-Talbot K, Becker LC (2006) Inhibition of TNF-alpha reduces myocardial injury and proinflammatory pathways following ischemia-reperfusion in the dog. J Cardiovasc Pharmacol 48:320\u2013328. https:\/\/doi.org\/10.1097\/01.fjc.0000250079.46526.38","journal-title":"J Cardiovasc Pharmacol"},{"key":"863_CR94","doi-asserted-by":"publisher","first-page":"6753","DOI":"10.1073\/pnas.86.17.6753","volume":"86","author":"T Gulick","year":"1989","unstructured":"Gulick T, Chung MK, Pieper SJ, Lange LG, Schreiner GF (1989) Interleukin 1 and tumor necrosis factor inhibit cardiac myocyte beta-adrenergic responsiveness. Proc Natl Acad Sci USA 86:6753\u20136757. https:\/\/doi.org\/10.1073\/pnas.86.17.6753","journal-title":"Proc Natl Acad Sci USA"},{"key":"863_CR95","doi-asserted-by":"publisher","first-page":"e1904607","DOI":"10.1002\/adma.201904607","volume":"31","author":"J Guo","year":"2019","unstructured":"Guo J, Li D, Tao H, Li G, Liu R, Dou Y, Jin T, Li L, Huang J, Hu H, Zhang J (2019) Cyclodextrin-derived intrinsically bioactive nanoparticles for treatment of acute and chronic inflammatory diseases. Adv Mater 31:e1904607. https:\/\/doi.org\/10.1002\/adma.201904607","journal-title":"Adv Mater"},{"key":"863_CR96","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1016\/j.yjmcc.2004.12.015","volume":"38","author":"D Gurantz","year":"2005","unstructured":"Gurantz D, Cowling RT, Varki N, Frikovsky E, Moore CD, Greenberg BH (2005) IL-1beta and TNF-alpha upregulate angiotensin II type 1 (AT1) receptors on cardiac fibroblasts and are associated with increased AT1 density in the post-MI heart. J Mol Cell Cardiol 38:505\u2013515. https:\/\/doi.org\/10.1016\/j.yjmcc.2004.12.015","journal-title":"J Mol Cell Cardiol"},{"key":"863_CR97","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.cardiores.2005.02.016","volume":"67","author":"D Gurantz","year":"2005","unstructured":"Gurantz D, Yndestad A, Halvorsen B, Lunde OV, Omens JH, Ueland T, Aukrust P, Moore CD, Kjekshus J, Greenberg BH (2005) Etanercept or intravenous immunoglobulin attenuates expression of genes involved in post-myocardial infarction remodeling. Cardiovasc Res 67:106\u2013115. https:\/\/doi.org\/10.1016\/j.cardiores.2005.02.016","journal-title":"Cardiovasc Res"},{"key":"863_CR98","doi-asserted-by":"publisher","first-page":"1386","DOI":"10.1161\/CIRCULATIONAHA.108.802918","volume":"119","author":"T Hamid","year":"2009","unstructured":"Hamid T, Gu Y, Ortines RV, Bhattacharya C, Wang G, Xuan YT, Prabhu SD (2009) Divergent tumor necrosis factor receptor-related remodeling responses in heart failure: role of nuclear factor-kappaB and inflammatory activation. Circulation 119:1386\u20131397. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.108.802918","journal-title":"Circulation"},{"key":"863_CR99","doi-asserted-by":"publisher","first-page":"140","DOI":"10.3389\/fcvm.2019.00140","volume":"6","author":"A Hanna","year":"2019","unstructured":"Hanna A, Frangogiannis NG (2019) The role of the TGF-beta superfamily in myocardial infarction. Front Cardiovasc Med 6:140. https:\/\/doi.org\/10.3389\/fcvm.2019.00140","journal-title":"Front Cardiovasc Med"},{"key":"863_CR100","doi-asserted-by":"publisher","first-page":"2007","DOI":"10.1073\/pnas.94.5.2007","volume":"94","author":"H Hara","year":"1997","unstructured":"Hara H, Friedlander RM, Gagliardini V, Ayata C, Fink K, Huang Z, Shimizu-Sasamata M, Yuan J, Moskowitz MA (1997) Inhibition of interleukin 1beta converting enzyme family proteases reduces ischemic and excitotoxic neuronal damage. Proc Natl Acad Sci USA 94:2007\u20132012. https:\/\/doi.org\/10.1073\/pnas.94.5.2007","journal-title":"Proc Natl Acad Sci USA"},{"key":"863_CR101","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1016\/j.jacbts.2017.06.005","volume":"2","author":"N Harouki","year":"2017","unstructured":"Harouki N, Nicol L, Remy-Jouet I, Henry JP, Dumesnil A, Lejeune A, Renet S, Golding F, Djerada Z, Wecker D, Bolduc V, Bouly M, Roussel J, Richard V, Mulder P (2017) The IL-1beta antibody gevokizumab limits cardiac remodeling and coronary dysfunction in rats with heart failure. JACC Basic Transl Sci 2:418\u2013430. https:\/\/doi.org\/10.1016\/j.jacbts.2017.06.005","journal-title":"JACC Basic Transl Sci"},{"key":"863_CR102","doi-asserted-by":"publisher","first-page":"e0167195","DOI":"10.1371\/journal.pone.0167195","volume":"11","author":"MH Hartman","year":"2016","unstructured":"Hartman MH, Vreeswijk-Baudoin I, Groot HE, van de Kolk KW, de Boer RA, Mateo Leach I, Vliegenthart R, Sillje HH, van der Harst P (2016) Inhibition of interleukin-6 receptor in a murine model of myocardial ischemia-reperfusion. PLoS ONE 11:e0167195. https:\/\/doi.org\/10.1371\/journal.pone.0167195","journal-title":"PLoS ONE"},{"key":"863_CR103","doi-asserted-by":"crossref","first-page":"4015","DOI":"10.4049\/jimmunol.143.12.4015","volume":"143","author":"CM Hawrylowicz","year":"1989","unstructured":"Hawrylowicz CM, Santoro SA, Platt FM, Unanue ER (1989) Activated platelets express IL-1 activity. J Immunol 143:4015\u20134018","journal-title":"J Immunol"},{"key":"863_CR104","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1038\/sj.jcbfm.9600086","volume":"25","author":"N Hosomi","year":"2005","unstructured":"Hosomi N, Ban CR, Naya T, Takahashi T, Guo P, Song XY, Kohno M (2005) Tumor necrosis factor-alpha neutralization reduced cerebral edema through inhibition of matrix metalloproteinase production after transient focal cerebral ischemia. J Cereb Blood Flow Metab 25:959\u2013967. https:\/\/doi.org\/10.1038\/sj.jcbfm.9600086","journal-title":"J Cereb Blood Flow Metab"},{"key":"863_CR105","doi-asserted-by":"publisher","first-page":"2364","DOI":"10.1161\/01.atv.19.10.2364","volume":"19","author":"SA Huber","year":"1999","unstructured":"Huber SA, Sakkinen P, Conze D, Hardin N, Tracy R (1999) Interleukin-6 exacerbates early atherosclerosis in mice. Arterioscler Thromb Vasc Biol 19:2364\u20132367. https:\/\/doi.org\/10.1161\/01.atv.19.10.2364","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"863_CR106","doi-asserted-by":"publisher","first-page":"2610","DOI":"10.1161\/01.cir.103.21.2610","volume":"103","author":"SA Huber","year":"2001","unstructured":"Huber SA, Sakkinen P, David C, Newell MK, Tracy RP (2001) T helper-cell phenotype regulates atherosclerosis in mice under conditions of mild hypercholesterolemia. Circulation 103:2610\u20132616. https:\/\/doi.org\/10.1161\/01.cir.103.21.2610","journal-title":"Circulation"},{"key":"863_CR107","doi-asserted-by":"publisher","first-page":"1546","DOI":"10.1016\/s0735-1097(01)01591-1","volume":"38","author":"MW Hwang","year":"2001","unstructured":"Hwang MW, Matsumori A, Furukawa Y, Ono K, Okada M, Iwasaki A, Hara M, Miyamoto T, Touma M, Sasayama S (2001) Neutralization of interleukin-1beta in the acute phase of myocardial infarction promotes the progression of left ventricular remodeling. J Am Coll Cardiol 38:1546\u20131553. https:\/\/doi.org\/10.1016\/s0735-1097(01)01591-1","journal-title":"J Am Coll Cardiol"},{"key":"863_CR108","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1016\/j.jacc.2019.05.024","volume":"74","author":"B Ibanez","year":"2019","unstructured":"Ibanez B, Aletras AH, Arai AE, Arheden H, Bax J, Berry C, Bucciarelli-Ducci C, Croisille P, Dall\u2019Armellina E, Dharmakumar R, Eitel I, Fernandez-Jimenez R, Friedrich MG, Garcia-Dorado D, Hausenloy DJ, Kim RJ, Kozerke S, Kramer CM, Salerno M, Sanchez-Gonzalez J, Sanz J, Fuster V (2019) Cardiac MRI endpoints in myocardial infarction experimental and clinical trials: JACC scientific expert panel. J Am Coll Cardiol 74:238\u2013256. https:\/\/doi.org\/10.1016\/j.jacc.2019.05.024","journal-title":"J Am Coll Cardiol"},{"key":"863_CR109","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1126\/science.aal3535","volume":"356","author":"WKE Ip","year":"2017","unstructured":"Ip WKE, Hoshi N, Shouval DS, Snapper S, Medzhitov R (2017) Anti-inflammatory effect of IL-10 mediated by metabolic reprogramming of macrophages. Science 356:513\u2013519. https:\/\/doi.org\/10.1126\/science.aal3535","journal-title":"Science"},{"key":"863_CR110","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.1161\/01.ATV.0000127025.48140.a3","volume":"24","author":"K Isoda","year":"2004","unstructured":"Isoda K, Sawada S, Ishigami N, Matsuki T, Miyazaki K, Kusuhara M, Iwakura Y, Ohsuzu F (2004) Lack of interleukin-1 receptor antagonist modulates plaque composition in apolipoprotein E-deficient mice. Arterioscler Thromb Vasc Biol 24:1068\u20131073. https:\/\/doi.org\/10.1161\/01.ATV.0000127025.48140.a3","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"863_CR111","doi-asserted-by":"publisher","first-page":"189292","DOI":"10.1155\/2015\/189292","volume":"2015","author":"N Iwata","year":"2015","unstructured":"Iwata N, Takayama H, Xuan M, Kamiuchi S, Matsuzaki H, Okazaki M, Hibino Y (2015) Effects of etanercept against transient cerebral ischemia in diabetic rats. Biomed Res Int 2015:189292. https:\/\/doi.org\/10.1155\/2015\/189292","journal-title":"Biomed Res Int"},{"key":"863_CR112","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.jaut.2012.07.009","volume":"40","author":"JO Jin","year":"2013","unstructured":"Jin JO, Han X, Yu Q (2013) Interleukin-6 induces the generation of IL-10-producing Tr1 cells and suppresses autoimmune tissue inflammation. J Autoimmun 40:28\u201344. https:\/\/doi.org\/10.1016\/j.jaut.2012.07.009","journal-title":"J Autoimmun"},{"key":"863_CR113","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1007\/s00011-016-0931-4","volume":"65","author":"WM Jong","year":"2016","unstructured":"Jong WM, Ten Cate H, Linnenbank AC, de Boer OJ, Reitsma PH, de Winter RJ, Zuurbier CJ (2016) Reduced acute myocardial ischemia-reperfusion injury in IL-6-deficient mice employing a closed-chest model. Inflamm Res 65:489\u2013499. https:\/\/doi.org\/10.1007\/s00011-016-0931-4","journal-title":"Inflamm Res"},{"key":"863_CR114","doi-asserted-by":"publisher","first-page":"1573","DOI":"10.1161\/01.atv.16.12.1573","volume":"16","author":"S Jovinge","year":"1996","unstructured":"Jovinge S, Ares MP, Kallin B, Nilsson J (1996) Human monocytes\/macrophages release TNF-alpha in response to Ox-LDL. Arterioscler Thromb Vasc Biol 16:1573\u20131579. https:\/\/doi.org\/10.1161\/01.atv.16.12.1573","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"863_CR115","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1007\/s00395-017-0622-5","volume":"112","author":"M Jung","year":"2017","unstructured":"Jung M, Ma Y, Iyer RP, DeLeon-Pennell KY, Yabluchanskiy A, Garrett MR, Lindsey ML (2017) IL-10 improves cardiac remodeling after myocardial infarction by stimulating M2 macrophage polarization and fibroblast activation. Basic Res Cardiol 112:33. https:\/\/doi.org\/10.1007\/s00395-017-0622-5","journal-title":"Basic Res Cardiol"},{"key":"863_CR116","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1161\/01.RES.0000177893.24574.13","volume":"97","author":"M Kamimura","year":"2005","unstructured":"Kamimura M, Viedt C, Dalpke A, Rosenfeld ME, Mackman N, Cohen DM, Blessing E, Preusch M, Weber CM, Kreuzer J, Katus HA, Bea F (2005) Interleukin-10 suppresses tissue factor expression in lipopolysaccharide-stimulated macrophages via inhibition of Egr-1 and a serum response element\/MEK-ERK1\/2 pathway. Circ Res 97:305\u2013313. https:\/\/doi.org\/10.1161\/01.RES.0000177893.24574.13","journal-title":"Circ Res"},{"key":"863_CR117","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20236008","author":"S Kany","year":"2019","unstructured":"Kany S, Vollrath JT, Relja B (2019) Cytokines in inflammatory disease. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms20236008","journal-title":"Int J Mol Sci"},{"key":"863_CR118","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1089\/wound.2013.0461","volume":"3","author":"A King","year":"2014","unstructured":"King A, Balaji S, Le LD, Crombleholme TM, Keswani SG (2014) Regenerative wound healing: the role of interleukin-10. Adv Wound Care (New Rochelle) 3:315\u2013323. https:\/\/doi.org\/10.1089\/wound.2013.0461","journal-title":"Adv Wound Care (New Rochelle)"},{"key":"863_CR119","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1161\/hq0302.104905","volume":"22","author":"VL King","year":"2002","unstructured":"King VL, Szilvassy SJ, Daugherty A (2002) Interleukin-4 deficiency decreases atherosclerotic lesion formation in a site-specific manner in female LDL receptor-\/- mice. Arterioscler Thromb Vasc Biol 22:456\u2013461. https:\/\/doi.org\/10.1161\/hq0302.104905","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"863_CR120","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1161\/01.ATV.0000064374.15232.C3","volume":"23","author":"H Kirii","year":"2003","unstructured":"Kirii H, Niwa T, Yamada Y, Wada H, Saito K, Iwakura Y, Asano M, Moriwaki H, Seishima M (2003) Lack of interleukin-1beta decreases the severity of atherosclerosis in ApoE-deficient mice. Arterioscler Thromb Vasc Biol 23:656\u2013660. https:\/\/doi.org\/10.1161\/01.ATV.0000064374.15232.C3","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"863_CR121","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1007\/s11914-020-00599-y","volume":"18","author":"B Kirk","year":"2020","unstructured":"Kirk B, Feehan J, Lombardi G, Duque G (2020) Muscle, bone, and fat crosstalk: the biological role of myokines, osteokines, and adipokines. Curr Osteoporos Rep 18:388\u2013400. https:\/\/doi.org\/10.1007\/s11914-020-00599-y","journal-title":"Curr Osteoporos Rep"},{"key":"863_CR122","doi-asserted-by":"publisher","first-page":"759610","DOI":"10.1155\/2015\/759610","volume":"2015","author":"B Kisiel","year":"2015","unstructured":"Kisiel B, Kruszewski R, Juszkiewicz A, Raczkiewicz A, Bachta A, Tlustochowicz M, Staniszewska-Varga J, Klos K, Duda K, Boguslawska-Walecka R, Ploski R, Tlustochowicz W (2015) Methotrexate, cyclosporine A, and biologics protect against atherosclerosis in rheumatoid arthritis. J Immunol Res 2015:759610. https:\/\/doi.org\/10.1155\/2015\/759610","journal-title":"J Immunol Res"},{"key":"863_CR123","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1161\/CIRCRESAHA.110.235713","volume":"108","author":"P Kleinbongard","year":"2011","unstructured":"Kleinbongard P, Bose D, Baars T, Mohlenkamp S, Konorza T, Schoner S, Elter-Schulz M, Eggebrecht H, Degen H, Haude M, Levkau B, Schulz R, Erbel R, Heusch G (2011) Vasoconstrictor potential of coronary aspirate from patients undergoing stenting of saphenous vein aortocoronary bypass grafts and its pharmacological attenuation. Circ Res 108:344\u2013352. https:\/\/doi.org\/10.1161\/CIRCRESAHA.110.235713","journal-title":"Circ Res"},{"key":"863_CR124","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1016\/j.yjmcc.2011.06.022","volume":"52","author":"P Kleinbongard","year":"2012","unstructured":"Kleinbongard P, Konorza T, Bose D, Baars T, Haude M, Erbel R, Heusch G (2012) Lessons from human coronary aspirate. J Mol Cell Cardiol 52:890\u2013896. https:\/\/doi.org\/10.1016\/j.yjmcc.2011.06.022","journal-title":"J Mol Cell Cardiol"},{"key":"863_CR125","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1007\/s10741-010-9180-8","volume":"16","author":"P Kleinbongard","year":"2011","unstructured":"Kleinbongard P, Schulz R, Heusch G (2011) TNFalpha in myocardial ischemia\/reperfusion, remodeling and heart failure. Heart Fail Rev 16:49\u201369. https:\/\/doi.org\/10.1007\/s10741-010-9180-8","journal-title":"Heart Fail Rev"},{"key":"863_CR126","doi-asserted-by":"publisher","first-page":"2406","DOI":"10.1093\/eurheartj\/ehw171","volume":"37","author":"O Kleveland","year":"2016","unstructured":"Kleveland O, Kunszt G, Bratlie M, Ueland T, Broch K, Holte E, Michelsen AE, Bendz B, Amundsen BH, Espevik T, Aakhus S, Damas JK, Aukrust P, Wiseth R, Gullestad L (2016) Effect of a single dose of the interleukin-6 receptor antagonist tocilizumab on inflammation and troponin T release in patients with non-ST-elevation myocardial infarction: a double-blind, randomized, placebo-controlled phase 2 trial. Eur Heart J 37:2406\u20132413. https:\/\/doi.org\/10.1093\/eurheartj\/ehw171","journal-title":"Eur Heart J"},{"key":"863_CR127","doi-asserted-by":"publisher","first-page":"e93","DOI":"10.1016\/j.atherosclerosis.2007.06.015","volume":"195","author":"F Kober","year":"2007","unstructured":"Kober F, Canault M, Peiretti F, Mueller C, Kopp F, Alessi MC, Cozzone PJ, Nalbone G, Bernard M (2007) MRI follow-up of TNF-dependent differential progression of atherosclerotic wall-thickening in mouse aortic arch from early to advanced stages. Atherosclerosis 195:e93-99. https:\/\/doi.org\/10.1016\/j.atherosclerosis.2007.06.015","journal-title":"Atherosclerosis"},{"key":"863_CR128","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1124\/molpharm.120.000056","volume":"98","author":"C Koch","year":"2020","unstructured":"Koch C, Engele J (2020) Functions of the CXCL12 receptor ACKR3\/CXCR7-what has been perceived and what has been overlooked. Mol Pharmacol 98:577\u2013585. https:\/\/doi.org\/10.1124\/molpharm.120.000056","journal-title":"Mol Pharmacol"},{"key":"863_CR129","doi-asserted-by":"publisher","first-page":"e9","DOI":"10.1161\/CIRCRESAHA.108.188243","volume":"104","author":"P Krishnamurthy","year":"2009","unstructured":"Krishnamurthy P, Rajasingh J, Lambers E, Qin G, Losordo DW, Kishore R (2009) IL-10 inhibits inflammation and attenuates left ventricular remodeling after myocardial infarction via activation of STAT3 and suppression of HuR. Circ Res 104:e9-18. https:\/\/doi.org\/10.1161\/CIRCRESAHA.108.188243","journal-title":"Circ Res"},{"key":"863_CR130","doi-asserted-by":"publisher","first-page":"2079","DOI":"10.1007\/s00296-017-3844-9","volume":"37","author":"K Kume","year":"2017","unstructured":"Kume K, Amano K, Yamada S, Kanazawa T, Ohta H, Hatta K, Amano K, Kuwaba N (2017) Tofacitinib improves atherosclerosis despite up-regulating serum cholesterol in patients with active rheumatoid arthritis: a cohort study. Rheumatol Int 37:2079\u20132085. https:\/\/doi.org\/10.1007\/s00296-017-3844-9","journal-title":"Rheumatol Int"},{"key":"863_CR131","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1007\/s00395-004-0509-0","volume":"100","author":"F Labruto","year":"2005","unstructured":"Labruto F, Yang J, Vaage J, Valen G (2005) Role of tumor necrosis factor alpha and its receptor I in preconditioning by hyperoxia. Basic Res Cardiol 100:198\u2013207. https:\/\/doi.org\/10.1007\/s00395-004-0509-0","journal-title":"Basic Res Cardiol"},{"key":"863_CR132","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.1523\/JNEUROSCI.5505-08.2009","volume":"29","author":"KL Lambertsen","year":"2009","unstructured":"Lambertsen KL, Clausen BH, Babcock AA, Gregersen R, Fenger C, Nielsen HH, Haugaard LS, Wirenfeldt M, Nielsen M, Dagnaes-Hansen F, Bluethmann H, Faergeman NJ, Meldgaard M, Deierborg T, Finsen B (2009) Microglia protect neurons against ischemia by synthesis of tumor necrosis factor. J Neurosci 29:1319\u20131330. https:\/\/doi.org\/10.1523\/JNEUROSCI.5505-08.2009","journal-title":"J Neurosci"},{"key":"863_CR133","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehaa099","author":"PR Lawler","year":"2020","unstructured":"Lawler PR, Bhatt DL, Godoy LC, Luscher TF, Bonow RO, Verma S, Ridker PM (2020) Targeting cardiovascular inflammation: next steps in clinical translation. Eur Heart J. https:\/\/doi.org\/10.1093\/eurheartj\/ehaa099","journal-title":"Eur Heart J"},{"key":"863_CR134","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1002\/jcp.22142","volume":"224","author":"IT Lee","year":"2010","unstructured":"Lee IT, Lin CC, Wu YC, Yang CM (2010) TNF-alpha induces matrix metalloproteinase-9 expression in A549 cells: role of TNFR1\/TRAF2\/PKCalpha-dependent signaling pathways. J Cell Physiol 224:454\u2013464. https:\/\/doi.org\/10.1002\/jcp.22142","journal-title":"J Cell Physiol"},{"key":"863_CR135","doi-asserted-by":"publisher","first-page":"149","DOI":"10.4062\/biomolther.2016.050","volume":"25","author":"JH Lee","year":"2017","unstructured":"Lee JH, Kam EH, Kim JM, Kim SY, Kim EJ, Cheon SY, Koo BN (2017) Intranasal administration of interleukin-1 receptor antagonist in a transient focal cerebral ischemia rat model. Biomol Ther (Seoul) 25:149\u2013157. https:\/\/doi.org\/10.4062\/biomolther.2016.050","journal-title":"Biomol Ther (Seoul)"},{"key":"863_CR136","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1007\/BF03020341","volume":"35","author":"MR Lessard","year":"1988","unstructured":"Lessard MR, Trepanier CA, Gourdeau M, Denault PH (1988) A microbiological study of the contamination of the syringes used in anaesthesia practice. Can J Anaesth 35:567\u2013569. https:\/\/doi.org\/10.1007\/BF03020341","journal-title":"Can J Anaesth"},{"key":"863_CR137","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1016\/s0002-8703(99)70375-3","volume":"137","author":"D Li","year":"1999","unstructured":"Li D, Zhao L, Liu M, Du X, Ding W, Zhang J, Mehta JL (1999) Kinetics of tumor necrosis factor alpha in plasma and the cardioprotective effect of a monoclonal antibody to tumor necrosis factor alpha in acute myocardial infarction. Am Heart J 137:1145\u20131152. https:\/\/doi.org\/10.1016\/s0002-8703(99)70375-3","journal-title":"Am Heart J"},{"key":"863_CR138","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1038\/nature01323","volume":"420","author":"P Libby","year":"2002","unstructured":"Libby P (2002) Inflammation in atherosclerosis. Nature 420:868\u2013874. https:\/\/doi.org\/10.1038\/nature01323","journal-title":"Nature"},{"key":"863_CR139","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1161\/CIRCULATIONAHA.120.046301","volume":"142","author":"L Liberale","year":"2020","unstructured":"Liberale L, Bonetti NR, Puspitasari YM, Schwarz L, Akhmedov A, Montecucco F, Ruschitzka F, Beer JH, Luscher TF, Simard J, Libby P, Camici GG (2020) Postischemic administration of IL-1alpha neutralizing antibody reduces brain damage and neurological deficit in experimental stroke. Circulation 142:187\u2013189. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.120.046301","journal-title":"Circulation"},{"key":"863_CR140","doi-asserted-by":"publisher","first-page":"105735","DOI":"10.1016\/j.biocel.2020.105735","volume":"122","author":"L Liberale","year":"2020","unstructured":"Liberale L, Carbone F, Montecucco F, Sahebkar A (2020) Statins reduce vascular inflammation in atherogenesis: a review of underlying molecular mechanisms. Int J Biochem Cell Biol 122:105735. https:\/\/doi.org\/10.1016\/j.biocel.2020.105735","journal-title":"Int J Biochem Cell Biol"},{"key":"863_CR141","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1160\/TH16-08-0593","volume":"117","author":"L Liberale","year":"2017","unstructured":"Liberale L, Dallegri F, Montecucco F, Carbone F (2017) Pathophysiological relevance of macrophage subsets in atherogenesis. Thromb Haemost 117:7\u201318. https:\/\/doi.org\/10.1160\/TH16-08-0593","journal-title":"Thromb Haemost"},{"key":"863_CR142","doi-asserted-by":"publisher","first-page":"3511","DOI":"10.1093\/eurheartj\/ehy286","volume":"39","author":"L Liberale","year":"2018","unstructured":"Liberale L, Diaz-Canestro C, Bonetti NR, Paneni F, Akhmedov A, Beer JH, Montecucco F, Luscher TF, Camici GG (2018) Post-ischaemic administration of the murine Canakinumab-surrogate antibody improves outcome in experimental stroke. Eur Heart J 39:3511\u20133517. https:\/\/doi.org\/10.1093\/eurheartj\/ehy286","journal-title":"Eur Heart J"},{"key":"863_CR143","doi-asserted-by":"publisher","DOI":"10.3390\/jcm8122072","author":"L Liberale","year":"2019","unstructured":"Liberale L, Holy EW, Akhmedov A, Bonetti NR, Nietlispach F, Matter CM, Mach F, Montecucco F, Beer JH, Paneni F, Ruschitzka F, Libby P, Luscher TF, Camici GG (2019) Interleukin-1beta mediates arterial thrombus formation via NET-associated tissue factor. J Clin Med. https:\/\/doi.org\/10.3390\/jcm8122072","journal-title":"J Clin Med"},{"key":"863_CR144","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.2174\/0929867324666170303123734","volume":"24","author":"L Liberale","year":"2017","unstructured":"Liberale L, Montecucco F, Camici GG, Dallegri F, Vecchie A, Carbone F, Bonaventura A (2017) Treatment with proprotein convertase subtilisin\/kexin type 9 (PCSK9) inhibitors to reduce cardiovascular inflammation and outcomes. Curr Med Chem 24:1403\u20131416. https:\/\/doi.org\/10.2174\/0929867324666170303123734","journal-title":"Curr Med Chem"},{"key":"863_CR145","doi-asserted-by":"publisher","DOI":"10.1093\/cvr\/cvaa211","author":"L Liberale","year":"2020","unstructured":"Liberale L, Montecucco F, Schwarz L, Luscher TF, Camici GG (2020) Inflammation and cardiovascular diseases: lessons from seminal clinical trials. Cardiovasc Res. https:\/\/doi.org\/10.1093\/cvr\/cvaa211","journal-title":"Cardiovasc Res"},{"key":"863_CR146","doi-asserted-by":"publisher","first-page":"2974","DOI":"10.1093\/eurheartj\/ehz961","volume":"41","author":"L Liberale","year":"2020","unstructured":"Liberale L, Montecucco F, Tardif JC, Libby P, Camici GG (2020) Inflamm-ageing: the role of inflammation in age-dependent cardiovascular disease. Eur Heart J 41:2974\u20132982. https:\/\/doi.org\/10.1093\/eurheartj\/ehz961","journal-title":"Eur Heart J"},{"key":"863_CR147","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.neulet.2014.07.003","volume":"579","author":"A Liesz","year":"2014","unstructured":"Liesz A, Bauer A, Hoheisel JD, Veltkamp R (2014) Intracerebral interleukin-10 injection modulates post-ischemic neuroinflammation: an experimental microarray study. Neurosci Lett 579:18\u201323. https:\/\/doi.org\/10.1016\/j.neulet.2014.07.003","journal-title":"Neurosci Lett"},{"key":"863_CR148","doi-asserted-by":"publisher","first-page":"2877","DOI":"10.1016\/j.neurobiolaging.2015.06.015","volume":"36","author":"M Liguz-Lecznar","year":"2015","unstructured":"Liguz-Lecznar M, Zakrzewska R, Kossut M (2015) Inhibition of Tnf-alpha R1 signaling can rescue functional cortical plasticity impaired in early post-stroke period. Neurobiol Aging 36:2877\u20132884. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2015.06.015","journal-title":"Neurobiol Aging"},{"key":"863_CR149","doi-asserted-by":"publisher","first-page":"757","DOI":"10.3858\/emm.2009.41.10.082","volume":"41","author":"JH Lim","year":"2009","unstructured":"Lim JH, Um HJ, Park JW, Lee IK, Kwon TK (2009) Interleukin-1beta promotes the expression of monocyte chemoattractant protein-1 in human aorta smooth muscle cells via multiple signaling pathways. Exp Mol Med 41:757\u2013764. https:\/\/doi.org\/10.3858\/emm.2009.41.10.082","journal-title":"Exp Mol Med"},{"key":"863_CR150","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1161\/STROKEAHA.115.012079","volume":"47","author":"X Liu","year":"2016","unstructured":"Liu X, Liu J, Zhao S, Zhang H, Cai W, Cai M, Ji X, Leak RK, Gao Y, Chen J, Hu X (2016) Interleukin-4 is essential for microglia\/macrophage M2 polarization and long-term recovery after cerebral ischemia. Stroke 47:498\u2013504. https:\/\/doi.org\/10.1161\/STROKEAHA.115.012079","journal-title":"Stroke"},{"key":"863_CR151","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1097\/00004647-199609000-00017","volume":"16","author":"SA Loddick","year":"1996","unstructured":"Loddick SA, Rothwell NJ (1996) Neuroprotective effects of human recombinant interleukin-1 receptor antagonist in focal cerebral ischaemia in the rat. J Cereb Blood Flow Metab 16:932\u2013940. https:\/\/doi.org\/10.1097\/00004647-199609000-00017","journal-title":"J Cereb Blood Flow Metab"},{"key":"863_CR152","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1006\/bbrc.1997.6436","volume":"234","author":"SA Loddick","year":"1997","unstructured":"Loddick SA, Wong ML, Bongiorno PB, Gold PW, Licinio J, Rothwell NJ (1997) Endogenous interleukin-1 receptor antagonist is neuroprotective. Biochem Biophys Res Commun 234:211\u2013215. https:\/\/doi.org\/10.1006\/bbrc.1997.6436","journal-title":"Biochem Biophys Res Commun"},{"key":"863_CR153","doi-asserted-by":"publisher","first-page":"1553","DOI":"10.1177\/0271678X15610339","volume":"36","author":"PM Madsen","year":"2016","unstructured":"Madsen PM, Clausen BH, Degn M, Thyssen S, Kristensen LK, Svensson M, Ditzel N, Finsen B, Deierborg T, Brambilla R, Lambertsen KL (2016) Genetic ablation of soluble tumor necrosis factor with preservation of membrane tumor necrosis factor is associated with neuroprotection after focal cerebral ischemia. J Cereb Blood Flow Metab 36:1553\u20131569. https:\/\/doi.org\/10.1177\/0271678X15610339","journal-title":"J Cereb Blood Flow Metab"},{"key":"863_CR154","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.1016\/s0735-1097(02)01738-2","volume":"39","author":"N Maekawa","year":"2002","unstructured":"Maekawa N, Wada H, Kanda T, Niwa T, Yamada Y, Saito K, Fujiwara H, Sekikawa K, Seishima M (2002) Improved myocardial ischemia\/reperfusion injury in mice lacking tumor necrosis factor-alpha. J Am Coll Cardiol 39:1229\u20131235. https:\/\/doi.org\/10.1016\/s0735-1097(02)01738-2","journal-title":"J Am Coll Cardiol"},{"key":"863_CR155","doi-asserted-by":"publisher","first-page":"e17","DOI":"10.1161\/01.res.85.8.e17","volume":"85","author":"Z Mallat","year":"1999","unstructured":"Mallat Z, Besnard S, Duriez M, Deleuze V, Emmanuel F, Bureau MF, Soubrier F, Esposito B, Duez H, Fievet C, Staels B, Duverger N, Scherman D, Tedgui A (1999) Protective role of interleukin-10 in atherosclerosis. Circ Res 85:e17-24. https:\/\/doi.org\/10.1161\/01.res.85.8.e17","journal-title":"Circ Res"},{"key":"863_CR156","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1161\/01.atv.19.3.611","volume":"19","author":"Z Mallat","year":"1999","unstructured":"Mallat Z, Heymes C, Ohan J, Faggin E, Leseche G, Tedgui A (1999) Expression of interleukin-10 in advanced human atherosclerotic plaques: relation to inducible nitric oxide synthase expression and cell death. Arterioscler Thromb Vasc Biol 19:611\u2013616. https:\/\/doi.org\/10.1161\/01.atv.19.3.611","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"863_CR157","doi-asserted-by":"publisher","first-page":"1210","DOI":"10.1038\/labinvest.3700322","volume":"85","author":"K Matsushita","year":"2005","unstructured":"Matsushita K, Iwanaga S, Oda T, Kimura K, Shimada M, Sano M, Umezawa A, Hata J, Ogawa S (2005) Interleukin-6\/soluble interleukin-6 receptor complex reduces infarct size via inhibiting myocardial apoptosis. Lab Invest 85:1210\u20131223. https:\/\/doi.org\/10.1038\/labinvest.3700322","journal-title":"Lab Invest"},{"key":"863_CR158","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.it.2014.12.008","volume":"36","author":"J Mauer","year":"2015","unstructured":"Mauer J, Denson JL, Bruning JC (2015) Versatile functions for IL-6 in metabolism and cancer. Trends Immunol 36:92\u2013101. https:\/\/doi.org\/10.1016\/j.it.2014.12.008","journal-title":"Trends Immunol"},{"key":"863_CR159","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1097\/FJC.0000000000000452","volume":"69","author":"AG Mauro","year":"2017","unstructured":"Mauro AG, Mezzaroma E, Torrado J, Kundur P, Joshi P, Stroud K, Quaini F, Lagrasta CA, Abbate A, Toldo S (2017) Reduction of myocardial ischemia-reperfusion injury by inhibiting interleukin-1 alpha. J Cardiovasc Pharmacol 69:156\u2013160. https:\/\/doi.org\/10.1097\/FJC.0000000000000452","journal-title":"J Cardiovasc Pharmacol"},{"key":"863_CR160","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1177\/0271678X15606714","volume":"36","author":"S Maysami","year":"2016","unstructured":"Maysami S, Wong R, Pradillo JM, Denes A, Dhungana H, Malm T, Koistinaho J, Orset C, Rahman M, Rubio M, Schwaninger M, Vivien D, Bath PM, Rothwell NJ, Allan SM (2016) A cross-laboratory preclinical study on the effectiveness of interleukin-1 receptor antagonist in stroke. J Cereb Blood Flow Metab 36:596\u2013605. https:\/\/doi.org\/10.1177\/0271678X15606714","journal-title":"J Cereb Blood Flow Metab"},{"key":"863_CR161","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1038\/s41586-019-0948-2","volume":"566","author":"CS McAlpine","year":"2019","unstructured":"McAlpine CS, Kiss MG, Rattik S, He S, Vassalli A, Valet C, Anzai A, Chan CT, Mindur JE, Kahles F, Poller WC, Frodermann V, Fenn AM, Gregory AF, Halle L, Iwamoto Y, Hoyer FF, Binder CJ, Libby P, Tafti M, Scammell TE, Nahrendorf M, Swirski FK (2019) Sleep modulates haematopoiesis and protects against atherosclerosis. Nature 566:383\u2013387. https:\/\/doi.org\/10.1038\/s41586-019-0948-2","journal-title":"Nature"},{"key":"863_CR162","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.12688\/f1000research.19308.2","volume":"8","author":"L McCulloch","year":"2019","unstructured":"McCulloch L, Allan SM, Emsley HC, Smith CJ, McColl BW (2019) Interleukin-1 receptor antagonist treatment in acute ischaemic stroke does not alter systemic markers of anti-microbial defence. F1000Res 8:1039. https:\/\/doi.org\/10.12688\/f1000research.19308.2","journal-title":"F1000Res"},{"key":"863_CR163","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1016\/j.cardiores.2005.01.008","volume":"66","author":"F Merhi-Soussi","year":"2005","unstructured":"Merhi-Soussi F, Kwak BR, Magne D, Chadjichristos C, Berti M, Pelli G, James RW, Mach F, Gabay C (2005) Interleukin-1 plays a major role in vascular inflammation and atherosclerosis in male apolipoprotein E-knockout mice. Cardiovasc Res 66:583\u2013593. https:\/\/doi.org\/10.1016\/j.cardiores.2005.01.008","journal-title":"Cardiovasc Res"},{"key":"863_CR164","doi-asserted-by":"publisher","first-page":"H1813","DOI":"10.1152\/ajpheart.00036.2004","volume":"287","author":"GW Moe","year":"2004","unstructured":"Moe GW, Marin-Garcia J, Konig A, Goldenthal M, Lu X, Feng Q (2004) In vivo TNF-alpha inhibition ameliorates cardiac mitochondrial dysfunction, oxidative stress, and apoptosis in experimental heart failure. Am J Physiol Heart Circ Physiol 287:H1813-1820. https:\/\/doi.org\/10.1152\/ajpheart.00036.2004","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"863_CR165","doi-asserted-by":"publisher","first-page":"342","DOI":"10.7150\/ntno.37391","volume":"3","author":"B Mog","year":"2019","unstructured":"Mog B, Asase C, Chaplin A, Gao H, Rajagopalan S, Maiseyeu A (2019) Nano-antagonist alleviates inflammation and allows for MRI of atherosclerosis. Nanotheranostics 3:342\u2013355. https:\/\/doi.org\/10.7150\/ntno.37391","journal-title":"Nanotheranostics"},{"key":"863_CR166","doi-asserted-by":"publisher","first-page":"e0179065","DOI":"10.1371\/journal.pone.0179065","volume":"12","author":"T Mohr","year":"2017","unstructured":"Mohr T, Haudek-Prinz V, Slany A, Grillari J, Micksche M, Gerner C (2017) Proteome profiling in IL-1beta and VEGF-activated human umbilical vein endothelial cells delineates the interlink between inflammation and angiogenesis. PLoS ONE 12:e0179065. https:\/\/doi.org\/10.1371\/journal.pone.0179065","journal-title":"PLoS ONE"},{"key":"863_CR167","doi-asserted-by":"publisher","first-page":"H743","DOI":"10.1152\/ajpheart.00166.2007","volume":"293","author":"Y Monden","year":"2007","unstructured":"Monden Y, Kubota T, Inoue T, Tsutsumi T, Kawano S, Ide T, Tsutsui H, Sunagawa K (2007) Tumor necrosis factor-alpha is toxic via receptor 1 and protective via receptor 2 in a murine model of myocardial infarction. Am J Physiol Heart Circ Physiol 293:H743-753. https:\/\/doi.org\/10.1152\/ajpheart.00166.2007","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"863_CR168","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1016\/j.cardiores.2005.06.026","volume":"68","author":"AC Morton","year":"2005","unstructured":"Morton AC, Arnold ND, Gunn J, Varcoe R, Francis SE, Dower SK, Crossman DC (2005) Interleukin-1 receptor antagonist alters the response to vessel wall injury in a porcine coronary artery model. Cardiovasc Res 68:493\u2013501. https:\/\/doi.org\/10.1016\/j.cardiores.2005.06.026","journal-title":"Cardiovasc Res"},{"key":"863_CR169","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1093\/cvr\/cvz042","volume":"115","author":"M Nash","year":"2019","unstructured":"Nash M, McGrath JP, Cartland SP, Patel S, Kavurma MM (2019) Tumour necrosis factor superfamily members in ischaemic vascular diseases. Cardiovasc Res 115:713\u2013720. https:\/\/doi.org\/10.1093\/cvr\/cvz042","journal-title":"Cardiovasc Res"},{"key":"863_CR170","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1097\/00004647-199702000-00013","volume":"17","author":"H Nawashiro","year":"1997","unstructured":"Nawashiro H, Martin D, Hallenbeck JM (1997) Inhibition of tumor necrosis factor and amelioration of brain infarction in mice. J Cereb Blood Flow Metab 17:229\u2013232. https:\/\/doi.org\/10.1097\/00004647-199702000-00013","journal-title":"J Cereb Blood Flow Metab"},{"key":"863_CR171","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/s0006-8993(97)00981-5","volume":"778","author":"H Nawashiro","year":"1997","unstructured":"Nawashiro H, Martin D, Hallenbeck JM (1997) Neuroprotective effects of TNF binding protein in focal cerebral ischemia. Brain Res 778:265\u2013271. https:\/\/doi.org\/10.1016\/s0006-8993(97)00981-5","journal-title":"Brain Res"},{"key":"863_CR172","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/s0022-4804(02)00038-0","volume":"109","author":"WH Newman","year":"2003","unstructured":"Newman WH, Castresana MR, Webb JG, Wang Z (2003) Cyclic AMP inhibits production of interleukin-6 and migration in human vascular smooth muscle cells. J Surg Res 109:57\u201361. https:\/\/doi.org\/10.1016\/s0022-4804(02)00038-0","journal-title":"J Surg Res"},{"key":"863_CR173","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1161\/ATVBAHA.118.312037","volume":"39","author":"H Noels","year":"2019","unstructured":"Noels H, Weber C, Koenen RR (2019) Chemokines as therapeutic targets in cardiovascular disease. Arterioscler Thromb Vasc Biol 39:583\u2013592. https:\/\/doi.org\/10.1161\/ATVBAHA.118.312037","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"863_CR174","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.atherosclerosis.2004.11.016","volume":"180","author":"H Ohta","year":"2005","unstructured":"Ohta H, Wada H, Niwa T, Kirii H, Iwamoto N, Fujii H, Saito K, Sekikawa K, Seishima M (2005) Disruption of tumor necrosis factor-alpha gene diminishes the development of atherosclerosis in ApoE-deficient mice. Atherosclerosis 180:11\u201317. https:\/\/doi.org\/10.1016\/j.atherosclerosis.2004.11.016","journal-title":"Atherosclerosis"},{"key":"863_CR175","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1161\/01.CIR.0000155622.68580.DC","volume":"111","author":"H Ooboshi","year":"2005","unstructured":"Ooboshi H, Ibayashi S, Shichita T, Kumai Y, Takada J, Ago T, Arakawa S, Sugimori H, Kamouchi M, Kitazono T, Iida M (2005) Postischemic gene transfer of interleukin-10 protects against both focal and global brain ischemia. Circulation 111:913\u2013919. https:\/\/doi.org\/10.1161\/01.CIR.0000155622.68580.DC","journal-title":"Circulation"},{"key":"863_CR176","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1111\/j.1365-2141.1995.tb05348.x","volume":"91","author":"L Ottonello","year":"1995","unstructured":"Ottonello L, Morone MP, Dapino P, Dallegri F (1995) Tumour necrosis factor alpha-induced oxidative burst in neutrophils adherent to fibronectin: effects of cyclic AMP-elevating agents. Br J Haematol 91:566\u2013570. https:\/\/doi.org\/10.1111\/j.1365-2141.1995.tb05348.x","journal-title":"Br J Haematol"},{"key":"863_CR177","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.200265","author":"G Ozen","year":"2020","unstructured":"Ozen G, Pedro S, Michaud K (2020) The risk of cardiovascular events associated with disease-modifying antirheumatic drugs in rheumatoid arthritis. J Rheumatol. https:\/\/doi.org\/10.3899\/jrheum.200265","journal-title":"J Rheumatol"},{"key":"863_CR178","doi-asserted-by":"publisher","first-page":"1330","DOI":"10.1136\/heartjnl-2013-303648","volume":"99","author":"GJ Padfield","year":"2013","unstructured":"Padfield GJ, Din JN, Koushiappi E, Mills NL, Robinson SD, Cruden Nle M, Lucking AJ, Chia S, Harding SA, Newby DE (2013) Cardiovascular effects of tumour necrosis factor alpha antagonism in patients with acute myocardial infarction: a first in human study. Heart 99:1330\u20131335. https:\/\/doi.org\/10.1136\/heartjnl-2013-303648","journal-title":"Heart"},{"key":"863_CR179","doi-asserted-by":"publisher","first-page":"1955","DOI":"10.1038\/jcbfm.2013.155","volume":"33","author":"I Perez-de Puig","year":"2013","unstructured":"Perez-de Puig I, Miro F, Salas-Perdomo A, Bonfill-Teixidor E, Ferrer-Ferrer M, Marquez-Kisinousky L, Planas AM (2013) IL-10 deficiency exacerbates the brain inflammatory response to permanent ischemia without preventing resolution of the lesion. J Cereb Blood Flow Metab 33:1955\u20131966. https:\/\/doi.org\/10.1038\/jcbfm.2013.155","journal-title":"J Cereb Blood Flow Metab"},{"key":"863_CR180","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1161\/01.RES.0000229685.37402.80","volume":"99","author":"A Picchi","year":"2006","unstructured":"Picchi A, Gao X, Belmadani S, Potter BJ, Focardi M, Chilian WM, Zhang C (2006) Tumor necrosis factor-alpha induces endothelial dysfunction in the prediabetic metabolic syndrome. Circ Res 99:69\u201377. https:\/\/doi.org\/10.1161\/01.RES.0000229685.37402.80","journal-title":"Circ Res"},{"key":"863_CR181","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1113\/expphysiol.2005.030734","volume":"90","author":"M Pickering","year":"2005","unstructured":"Pickering M, Cumiskey D, O\u2019Connor JJ (2005) Actions of TNF-alpha on glutamatergic synaptic transmission in the central nervous system. Exp Physiol 90:663\u2013670. https:\/\/doi.org\/10.1113\/expphysiol.2005.030734","journal-title":"Exp Physiol"},{"key":"863_CR182","doi-asserted-by":"publisher","first-page":"1992","DOI":"10.1182\/blood-2005-03-1247","volume":"106","author":"P Pignatelli","year":"2005","unstructured":"Pignatelli P, De Biase L, Lenti L, Tocci G, Brunelli A, Cangemi R, Riondino S, Grego S, Volpe M, Violi F (2005) Tumor necrosis factor-alpha as trigger of platelet activation in patients with heart failure. Blood 106:1992\u20131994. https:\/\/doi.org\/10.1182\/blood-2005-03-1247","journal-title":"Blood"},{"key":"863_CR183","doi-asserted-by":"publisher","first-page":"1064","DOI":"10.1161\/01.res.0000018941.10726.fa","volume":"90","author":"LJ Pinderski","year":"2002","unstructured":"Pinderski LJ, Fischbein MP, Subbanagounder G, Fishbein MC, Kubo N, Cheroutre H, Curtiss LK, Berliner JA, Boisvert WA (2002) Overexpression of interleukin-10 by activated T lymphocytes inhibits atherosclerosis in LDL receptor-deficient Mice by altering lymphocyte and macrophage phenotypes. Circ Res 90:1064\u20131071. https:\/\/doi.org\/10.1161\/01.res.0000018941.10726.fa","journal-title":"Circ Res"},{"key":"863_CR184","doi-asserted-by":"publisher","first-page":"R225","DOI":"10.1186\/ar4064","volume":"14","author":"J Pircher","year":"2012","unstructured":"Pircher J, Merkle M, Wornle M, Ribeiro A, Czermak T, Stampnik Y, Mannell H, Niemeyer M, Vielhauer V, Krotz F (2012) Prothrombotic effects of tumor necrosis factor alpha in vivo are amplified by the absence of TNF-alpha receptor subtype 1 and require TNF-alpha receptor subtype 2. Arthritis Res Ther 14:R225. https:\/\/doi.org\/10.1186\/ar4064","journal-title":"Arthritis Res Ther"},{"key":"863_CR185","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1006\/excr.1994.1296","volume":"214","author":"VA Polunovsky","year":"1994","unstructured":"Polunovsky VA, Wendt CH, Ingbar DH, Peterson MS, Bitterman PB (1994) Induction of endothelial cell apoptosis by TNF alpha: modulation by inhibitors of protein synthesis. Exp Cell Res 214:584\u2013594. https:\/\/doi.org\/10.1006\/excr.1994.1296","journal-title":"Exp Cell Res"},{"key":"863_CR186","doi-asserted-by":"publisher","first-page":"1474","DOI":"10.1161\/01.ATV.0000134378.86443.cd","volume":"24","author":"S Potteaux","year":"2004","unstructured":"Potteaux S, Esposito B, van Oostrom O, Brun V, Ardouin P, Groux H, Tedgui A, Mallat Z (2004) Leukocyte-derived interleukin 10 is required for protection against atherosclerosis in low-density lipoprotein receptor knockout mice. Arterioscler Thromb Vasc Biol 24:1474\u20131478. https:\/\/doi.org\/10.1161\/01.ATV.0000134378.86443.cd","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"863_CR187","doi-asserted-by":"publisher","first-page":"144900","DOI":"10.1016\/j.gene.2020.144900","volume":"755","author":"M Qin","year":"2020","unstructured":"Qin M, Wang W, Zhou H, Wang X, Wang F, Wang H (2020) Circular RNA circ_0003645 silencing alleviates inflammation and apoptosis via the NF-kappaB pathway in endothelial cells induced by oxLDL. Gene 755:144900. https:\/\/doi.org\/10.1016\/j.gene.2020.144900","journal-title":"Gene"},{"key":"863_CR188","doi-asserted-by":"publisher","first-page":"e11765","DOI":"10.1371\/journal.pone.0011765","volume":"5","author":"K Rajamaki","year":"2010","unstructured":"Rajamaki K, Lappalainen J, Oorni K, Valimaki E, Matikainen S, Kovanen PT, Eklund KK (2010) Cholesterol crystals activate the NLRP3 inflammasome in human macrophages: a novel link between cholesterol metabolism and inflammation. PLoS ONE 5:e11765. https:\/\/doi.org\/10.1371\/journal.pone.0011765","journal-title":"PLoS ONE"},{"key":"863_CR189","doi-asserted-by":"publisher","first-page":"H1369","DOI":"10.1152\/ajpheart.00641.2003","volume":"287","author":"R Ramani","year":"2004","unstructured":"Ramani R, Mathier M, Wang P, Gibson G, Togel S, Dawson J, Bauer A, Alber S, Watkins SC, McTiernan CF, Feldman AM (2004) Inhibition of tumor necrosis factor receptor-1-mediated pathways has beneficial effects in a murine model of postischemic remodeling. Am J Physiol Heart Circ Physiol 287:H1369-1377. https:\/\/doi.org\/10.1152\/ajpheart.00641.2003","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"863_CR190","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1038\/cdd.2011.93","volume":"19","author":"S Rastogi","year":"2012","unstructured":"Rastogi S, Rizwani W, Joshi B, Kunigal S, Chellappan SP (2012) TNF-alpha response of vascular endothelial and vascular smooth muscle cells involve differential utilization of ASK1 kinase and p73. Cell Death Differ 19:274\u2013283. https:\/\/doi.org\/10.1038\/cdd.2011.93","journal-title":"Cell Death Differ"},{"key":"863_CR191","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1006\/exnr.1996.0059","volume":"138","author":"JK Relton","year":"1996","unstructured":"Relton JK, Martin D, Thompson RC, Russell DA (1996) Peripheral administration of Interleukin-1 Receptor antagonist inhibits brain damage after focal cerebral ischemia in the rat. Exp Neurol 138:206\u2013213. https:\/\/doi.org\/10.1006\/exnr.1996.0059","journal-title":"Exp Neurol"},{"key":"863_CR192","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1056\/NEJMoa1707914","volume":"377","author":"PM Ridker","year":"2017","unstructured":"Ridker PM, Everett BM, Thuren T, MacFadyen JG, Chang WH, Ballantyne C, Fonseca F, Nicolau J, Koenig W, Anker SD, Kastelein JJP, Cornel JH, Pais P, Pella D, Genest J, Cifkova R, Lorenzatti A, Forster T, Kobalava Z, Vida-Simiti L, Flather M, Shimokawa H, Ogawa H, Dellborg M, Rossi PRF, Troquay RPT, Libby P, Glynn RJ, Group CT (2017) Antiinflammatory therapy with canakinumab for atherosclerotic disease. N Engl J Med 377:1119\u20131131. https:\/\/doi.org\/10.1056\/NEJMoa1707914","journal-title":"N Engl J Med"},{"key":"863_CR193","doi-asserted-by":"publisher","first-page":"8430123","DOI":"10.1155\/2018\/8430123","volume":"2018","author":"FR Rizzo","year":"2018","unstructured":"Rizzo FR, Musella A, De Vito F, Fresegna D, Bullitta S, Vanni V, Guadalupi L, Stampanoni Bassi M, Buttari F, Mandolesi G, Centonze D, Gentile A (2018) Tumor necrosis factor and interleukin-1beta modulate synaptic plasticity during neuroinflammation. Neural Plast 2018:8430123. https:\/\/doi.org\/10.1155\/2018\/8430123","journal-title":"Neural Plast"},{"key":"863_CR194","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1016\/0006-291x(92)91793-p","volume":"182","author":"R Robert","year":"1992","unstructured":"Robert R, Chapelain B, Jean T, Neliat G (1992) Interleukin-1 impairs both vascular contraction and relaxation in rabbit isolated aorta. Biochem Biophys Res Commun 182:733\u2013739. https:\/\/doi.org\/10.1016\/0006-291x(92)91793-p","journal-title":"Biochem Biophys Res Commun"},{"key":"863_CR195","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1056\/NEJM197608122950707","volume":"295","author":"R Ross","year":"1976","unstructured":"Ross R, Glomset JA (1976) The pathogenesis of atherosclerosis (first of two parts). N Engl J Med 295:369\u2013377. https:\/\/doi.org\/10.1056\/NEJM197608122950707","journal-title":"N Engl J Med"},{"key":"863_CR196","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1136\/annrheumdis-2014-206624","volume":"74","author":"C Roubille","year":"2015","unstructured":"Roubille C, Richer V, Starnino T, McCourt C, McFarlane A, Fleming P, Siu S, Kraft J, Lynde C, Pope J, Gulliver W, Keeling S, Dutz J, Bessette L, Bissonnette R, Haraoui B (2015) The effects of tumour necrosis factor inhibitors, methotrexate, non-steroidal anti-inflammatory drugs and corticosteroids on cardiovascular events in rheumatoid arthritis, psoriasis and psoriatic arthritis: a systematic review and meta-analysis. Ann Rheum Dis 74:480\u2013489. https:\/\/doi.org\/10.1136\/annrheumdis-2014-206624","journal-title":"Ann Rheum Dis"},{"key":"863_CR197","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.trsl.2016.12.003","volume":"183","author":"P Ruiz-Limon","year":"2017","unstructured":"Ruiz-Limon P, Ortega R, Arias de la Rosa I, Abalos-Aguilera MDC, Perez-Sanchez C, Jimenez-Gomez Y, Peralbo-Santaella E, Font P, Ruiz-Vilches D, Ferrin G, Collantes-Estevez E, Escudero-Contreras A, Lopez-Pedrera C, Barbarroja N (2017) Tocilizumab improves the proatherothrombotic profile of rheumatoid arthritis patients modulating endothelial dysfunction, NETosis, and inflammation. Transl Res 183:87\u2013103. https:\/\/doi.org\/10.1016\/j.trsl.2016.12.003","journal-title":"Transl Res"},{"key":"863_CR198","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/0021-9150(91)90066-c","volume":"89","author":"HG Rus","year":"1991","unstructured":"Rus HG, Niculescu F, Vlaicu R (1991) Tumor necrosis factor-alpha in human arterial wall with atherosclerosis. Atherosclerosis 89:247\u2013254. https:\/\/doi.org\/10.1016\/0021-9150(91)90066-c","journal-title":"Atherosclerosis"},{"key":"863_CR199","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1111\/jnc.13422","volume":"136","author":"K Salmeron","year":"2016","unstructured":"Salmeron K, Aihara T, Redondo-Castro E, Pinteaux E, Bix G (2016) IL-1alpha induces angiogenesis in brain endothelial cells in vitro: implications for brain angiogenesis after acute injury. J Neurochem 136:573\u2013580. https:\/\/doi.org\/10.1111\/jnc.13422","journal-title":"J Neurochem"},{"key":"863_CR200","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1186\/s12974-019-1599-9","volume":"16","author":"KE Salmeron","year":"2019","unstructured":"Salmeron KE, Maniskas ME, Edwards DN, Wong R, Rajkovic I, Trout A, Rahman AA, Hamilton S, Fraser JF, Pinteaux E, Bix GJ (2019) Interleukin 1 alpha administration is neuroprotective and neuro-restorative following experimental ischemic stroke. J Neuroinflamm 16:222. https:\/\/doi.org\/10.1186\/s12974-019-1599-9","journal-title":"J Neuroinflamm"},{"key":"863_CR201","doi-asserted-by":"publisher","first-page":"H1823","DOI":"10.1152\/ajpheart.2000.278.6.H1823","volume":"278","author":"S Sasu","year":"2000","unstructured":"Sasu S, Beasley D (2000) Essential roles of IkappaB kinases alpha and beta in serum- and IL-1-induced human VSMC proliferation. Am J Physiol Heart Circ Physiol 278:H1823-1831. https:\/\/doi.org\/10.1152\/ajpheart.2000.278.6.H1823","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"863_CR202","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1186\/s12974-015-0330-8","volume":"12","author":"A Savard","year":"2015","unstructured":"Savard A, Brochu ME, Chevin M, Guiraut C, Grbic D, Sebire G (2015) Neuronal self-injury mediated by IL-1beta and MMP-9 in a cerebral palsy model of severe neonatal encephalopathy induced by immune activation plus hypoxia-ischemia. J Neuroinflamm 12:111. https:\/\/doi.org\/10.1186\/s12974-015-0330-8","journal-title":"J Neuroinflamm"},{"key":"863_CR203","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1016\/j.bbamcr.2011.01.034","volume":"1813","author":"J Scheller","year":"2011","unstructured":"Scheller J, Chalaris A, Schmidt-Arras D, Rose-John S (2011) The pro- and anti-inflammatory properties of the cytokine interleukin-6. Biochim Biophys Acta 1813:878\u2013888. https:\/\/doi.org\/10.1016\/j.bbamcr.2011.01.034","journal-title":"Biochim Biophys Acta"},{"key":"863_CR204","doi-asserted-by":"publisher","first-page":"3493","DOI":"10.1161\/01.CIR.0000148135.08582.97","volume":"110","author":"B Schieffer","year":"2004","unstructured":"Schieffer B, Selle T, Hilfiker A, Hilfiker-Kleiner D, Grote K, Tietge UJ, Trautwein C, Luchtefeld M, Schmittkamp C, Heeneman S, Daemen MJ, Drexler H (2004) Impact of interleukin-6 on plaque development and morphology in experimental atherosclerosis. Circulation 110:3493\u20133500. https:\/\/doi.org\/10.1161\/01.CIR.0000148135.08582.97","journal-title":"Circulation"},{"key":"863_CR205","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.1016\/j.jhep.2016.02.004","volume":"64","author":"D Schmidt-Arras","year":"2016","unstructured":"Schmidt-Arras D, Rose-John S (2016) IL-6 pathway in the liver: from physiopathology to therapy. J Hepatol 64:1403\u20131415. https:\/\/doi.org\/10.1016\/j.jhep.2016.02.004","journal-title":"J Hepatol"},{"key":"863_CR206","doi-asserted-by":"publisher","first-page":"19569","DOI":"10.1074\/jbc.272.31.19569","volume":"272","author":"U Schonbeck","year":"1997","unstructured":"Schonbeck U, Mach F, Bonnefoy JY, Loppnow H, Flad HD, Libby P (1997) Ligation of CD40 activates interleukin 1beta-converting enzyme (caspase-1) activity in vascular smooth muscle and endothelial cells and promotes elaboration of active interleukin 1beta. J Biol Chem 272:19569\u201319574. https:\/\/doi.org\/10.1074\/jbc.272.31.19569","journal-title":"J Biol Chem"},{"key":"863_CR207","doi-asserted-by":"publisher","first-page":"26174","DOI":"10.1074\/jbc.271.42.26174","volume":"271","author":"SA Schreyer","year":"1996","unstructured":"Schreyer SA, Peschon JJ, LeBoeuf RC (1996) Accelerated atherosclerosis in mice lacking tumor necrosis factor receptor p55. J Biol Chem 271:26174\u201326178. https:\/\/doi.org\/10.1074\/jbc.271.42.26174","journal-title":"J Biol Chem"},{"key":"863_CR208","doi-asserted-by":"publisher","first-page":"H2927","DOI":"10.1152\/ajpheart.00700.2006","volume":"292","author":"K Schultz","year":"2007","unstructured":"Schultz K, Murthy V, Tatro JB, Beasley D (2007) Endogenous interleukin-1 alpha promotes a proliferative and proinflammatory phenotype in human vascular smooth muscle cells. Am J Physiol Heart Circ Physiol 292:H2927-2934. https:\/\/doi.org\/10.1152\/ajpheart.00700.2006","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"863_CR209","doi-asserted-by":"publisher","first-page":"1355","DOI":"10.1161\/CIRCULATIONAHA.108.846105","volume":"119","author":"R Schulz","year":"2009","unstructured":"Schulz R, Heusch G (2009) Tumor necrosis factor-alpha and its receptors 1 and 2: Yin and Yang in myocardial infarction? Circulation 119:1355\u20131357. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.108.846105","journal-title":"Circulation"},{"key":"863_CR210","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1007\/s11886-018-1067-7","volume":"20","author":"SM Schumacher","year":"2018","unstructured":"Schumacher SM, Naga Prasad SV (2018) Tumor necrosis factor-alpha in heart failure: an updated review. Curr Cardiol Rep 20:117. https:\/\/doi.org\/10.1007\/s11886-018-1067-7","journal-title":"Curr Cardiol Rep"},{"key":"863_CR211","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1172\/JCI118476","volume":"97","author":"H Shimokawa","year":"1996","unstructured":"Shimokawa H, Ito A, Fukumoto Y, Kadokami T, Nakaike R, Sakata M, Takayanagi T, Egashira K, Takeshita A (1996) Chronic treatment with interleukin-1 beta induces coronary intimal lesions and vasospastic responses in pigs in vivo. The role of platelet-derived growth factor. J Clin Invest 97:769\u2013776. https:\/\/doi.org\/10.1172\/JCI118476","journal-title":"J Clin Invest"},{"key":"863_CR212","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1161\/01.RES.0000255031.15793.86","volume":"100","author":"A Skyschally","year":"2007","unstructured":"Skyschally A, Gres P, Hoffmann S, Haude M, Erbel R, Schulz R, Heusch G (2007) Bidirectional role of tumor necrosis factor-alpha in coronary microembolization: progressive contractile dysfunction versus delayed protection against infarction. Circ Res 100:140\u2013146. https:\/\/doi.org\/10.1161\/01.RES.0000255031.15793.86","journal-title":"Circ Res"},{"key":"863_CR213","doi-asserted-by":"publisher","first-page":"1210","DOI":"10.1161\/STROKEAHA.118.020750","volume":"49","author":"CJ Smith","year":"2018","unstructured":"Smith CJ, Hulme S, Vail A, Heal C, Parry-Jones AR, Scarth S, Hopkins K, Hoadley M, Allan SM, Rothwell NJ, Hopkins SJ, Tyrrell PJ (2018) SCIL-STROKE (subcutaneous interleukin-1 receptor antagonist in ischemic stroke): a randomized controlled phase 2 trial. Stroke 49:1210\u20131216. https:\/\/doi.org\/10.1161\/STROKEAHA.118.020750","journal-title":"Stroke"},{"key":"863_CR214","doi-asserted-by":"publisher","first-page":"1746","DOI":"10.1161\/CIRCULATIONAHA.109.924886","volume":"121","author":"E Smith","year":"2010","unstructured":"Smith E, Prasad KM, Butcher M, Dobrian A, Kolls JK, Ley K, Galkina E (2010) Blockade of interleukin-17A results in reduced atherosclerosis in apolipoprotein E-deficient mice. Circulation 121:1746\u20131755. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.109.924886","journal-title":"Circulation"},{"key":"863_CR215","doi-asserted-by":"publisher","first-page":"2160","DOI":"10.1161\/STROKEAHA.115.010001","volume":"47","author":"OA Sobowale","year":"2016","unstructured":"Sobowale OA, Parry-Jones AR, Smith CJ, Tyrrell PJ, Rothwell NJ, Allan SM (2016) Interleukin-1 in stroke: from bench to bedside. Stroke 47:2160\u20132167. https:\/\/doi.org\/10.1161\/STROKEAHA.115.010001","journal-title":"Stroke"},{"key":"863_CR216","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/s0304-3940(98)00537-0","volume":"251","author":"PA Spera","year":"1998","unstructured":"Spera PA, Ellison JA, Feuerstein GZ, Barone FC (1998) IL-10 reduces rat brain injury following focal stroke. Neurosci Lett 251:189\u2013192. https:\/\/doi.org\/10.1016\/s0304-3940(98)00537-0","journal-title":"Neurosci Lett"},{"key":"863_CR217","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1016\/j.bbi.2009.02.015","volume":"23","author":"S Spulber","year":"2009","unstructured":"Spulber S, Bartfai T, Schultzberg M (2009) IL-1\/IL-1ra balance in the brain revisited\u2014evidence from transgenic mouse models. Brain Behav Immun 23:573\u2013579. https:\/\/doi.org\/10.1016\/j.bbi.2009.02.015","journal-title":"Brain Behav Immun"},{"key":"863_CR218","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1096\/fj.03-1148fje","volume":"18","author":"M Sugano","year":"2004","unstructured":"Sugano M, Tsuchida K, Hata T, Makino N (2004) In vivo transfer of soluble TNF-alpha receptor 1 gene improves cardiac function and reduces infarct size after myocardial infarction in rats. FASEB J 18:911\u2013913. https:\/\/doi.org\/10.1096\/fj.03-1148fje","journal-title":"FASEB J"},{"key":"863_CR219","doi-asserted-by":"publisher","first-page":"1933","DOI":"10.1038\/jcbfm.2012.97","volume":"32","author":"RK Sumbria","year":"2012","unstructured":"Sumbria RK, Boado RJ, Pardridge WM (2012) Brain protection from stroke with intravenous TNFalpha decoy receptor-Trojan horse fusion protein. J Cereb Blood Flow Metab 32:1933\u20131938. https:\/\/doi.org\/10.1038\/jcbfm.2012.97","journal-title":"J Cereb Blood Flow Metab"},{"key":"863_CR220","doi-asserted-by":"publisher","first-page":"e3074","DOI":"10.1038\/cddis.2017.470","volume":"8","author":"HJ Sun","year":"2017","unstructured":"Sun HJ, Ren XS, Xiong XQ, Chen YZ, Zhao MX, Wang JJ, Zhou YB, Han Y, Chen Q, Li YH, Kang YM, Zhu GQ (2017) NLRP3 inflammasome activation contributes to VSMC phenotypic transformation and proliferation in hypertension. Cell Death Dis 8:e3074. https:\/\/doi.org\/10.1038\/cddis.2017.470","journal-title":"Cell Death Dis"},{"key":"863_CR221","doi-asserted-by":"publisher","first-page":"I308","DOI":"10.1161\/hc37t1.094871","volume":"104","author":"K Suzuki","year":"2001","unstructured":"Suzuki K, Murtuza B, Smolenski RT, Sammut IA, Suzuki N, Kaneda Y, Yacoub MH (2001) Overexpression of interleukin-1 receptor antagonist provides cardioprotection against ischemia-reperfusion injury associated with reduction in apoptosis. Circulation 104:I308\u2013I303. https:\/\/doi.org\/10.1161\/hc37t1.094871","journal-title":"Circulation"},{"key":"863_CR222","doi-asserted-by":"publisher","first-page":"5821","DOI":"10.1111\/j.1742-4658.2005.04979.x","volume":"272","author":"M Swiatkowska","year":"2005","unstructured":"Swiatkowska M, Szemraj J, Cierniewski CS (2005) Induction of PAI-1 expression by tumor necrosis factor alpha in endothelial cells is mediated by its responsive element located in the 4G\/5G site. FEBS J 272:5821\u20135831. https:\/\/doi.org\/10.1111\/j.1742-4658.2005.04979.x","journal-title":"FEBS J"},{"key":"863_CR223","doi-asserted-by":"publisher","first-page":"C144","DOI":"10.1152\/ajpcell.2002.282.1.C144","volume":"282","author":"X Teng","year":"2002","unstructured":"Teng X, Zhang H, Snead C, Catravas JD (2002) Molecular mechanisms of iNOS induction by IL-1 beta and IFN-gamma in rat aortic smooth muscle cells. Am J Physiol Cell Physiol 282:C144-152. https:\/\/doi.org\/10.1152\/ajpcell.2002.282.1.C144","journal-title":"Am J Physiol Cell Physiol"},{"key":"863_CR224","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.brainres.2009.06.081","volume":"1287","author":"WL Thompson","year":"2009","unstructured":"Thompson WL, Van Eldik LJ (2009) Inflammatory cytokines stimulate the chemokines CCL2\/MCP-1 and CCL7\/MCP-3 through NFkB and MAPK dependent pathways in rat astrocytes [corrected]. Brain Res 1287:47\u201357. https:\/\/doi.org\/10.1016\/j.brainres.2009.06.081","journal-title":"Brain Res"},{"key":"863_CR225","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1182\/blood.V83.1.113.113","volume":"83","author":"H Tilg","year":"1994","unstructured":"Tilg H, Trehu E, Atkins MB, Dinarello CA, Mier JW (1994) Interleukin-6 (IL-6) as an anti-inflammatory cytokine: induction of circulating IL-1 receptor antagonist and soluble tumor necrosis factor receptor p55. Blood 83:113\u2013118","journal-title":"Blood"},{"key":"863_CR226","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1097\/FJC.0000000000000658","volume":"73","author":"S Toldo","year":"2019","unstructured":"Toldo S, Mauro AG, Cutter Z, Van Tassell BW, Mezzaroma E, Del Buono MG, Prestamburgo A, Potere N, Abbate A (2019) The NLRP3 inflammasome inhibitor, OLT1177 (dapansutrile), reduces infarct size and preserves contractile function after ischemia reperfusion injury in the mouse. J Cardiovasc Pharmacol 73:215\u2013222. https:\/\/doi.org\/10.1097\/FJC.0000000000000658","journal-title":"J Cardiovasc Pharmacol"},{"key":"863_CR227","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/FJC.0000000000000106","volume":"64","author":"S Toldo","year":"2014","unstructured":"Toldo S, Mezzaroma E, Bressi E, Marchetti C, Carbone S, Sonnino C, Van Tassell BW, Abbate A (2014) Interleukin-1beta blockade improves left ventricular systolic\/diastolic function and restores contractility reserve in severe ischemic cardiomyopathy in the mouse. J Cardiovasc Pharmacol 64:1\u20136. https:\/\/doi.org\/10.1097\/FJC.0000000000000106","journal-title":"J Cardiovasc Pharmacol"},{"key":"863_CR228","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1113\/expphysiol.2012.069831","volume":"98","author":"S Toldo","year":"2013","unstructured":"Toldo S, Mezzaroma E, Van Tassell BW, Farkas D, Marchetti C, Voelkel NF, Abbate A (2013) Interleukin-1beta blockade improves cardiac remodelling after myocardial infarction without interrupting the inflammasome in the mouse. Exp Physiol 98:734\u2013745. https:\/\/doi.org\/10.1113\/expphysiol.2012.069831","journal-title":"Exp Physiol"},{"key":"863_CR229","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1007\/s10557-012-6389-x","volume":"26","author":"S Toldo","year":"2012","unstructured":"Toldo S, Schatz AM, Mezzaroma E, Chawla R, Stallard TW, Stallard WC, Jahangiri A, Van Tassell BW, Abbate A (2012) Recombinant human interleukin-1 receptor antagonist provides cardioprotection during myocardial ischemia reperfusion in the mouse. Cardiovasc Drugs Ther 26:273\u2013276. https:\/\/doi.org\/10.1007\/s10557-012-6389-x","journal-title":"Cardiovasc Drugs Ther"},{"key":"863_CR230","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1182\/blood.V75.6.1305.1305","volume":"75","author":"G Tosato","year":"1990","unstructured":"Tosato G, Jones KD (1990) Interleukin-1 induces interleukin-6 production in peripheral blood monocytes. Blood 75:1305\u20131310","journal-title":"Blood"},{"key":"863_CR231","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1007\/s10557-008-6130-y","volume":"22","author":"MC Toufektsian","year":"2008","unstructured":"Toufektsian MC, Robbez-Masson V, Sanou D, Jouan MG, Ormezzano O, de Leiris J, Boucher F (2008) A single intravenous sTNFR-Fc administration at the time of reperfusion limits infarct size\u2013implications in reperfusion strategies in man. Cardiovasc Drugs Ther 22:437\u2013442. https:\/\/doi.org\/10.1007\/s10557-008-6130-y","journal-title":"Cardiovasc Drugs Ther"},{"key":"863_CR232","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1016\/j.it.2010.05.005","volume":"31","author":"L Tourneur","year":"2010","unstructured":"Tourneur L, Chiocchia G (2010) FADD: a regulator of life and death. Trends Immunol 31:260\u2013269. https:\/\/doi.org\/10.1016\/j.it.2010.05.005","journal-title":"Trends Immunol"},{"key":"863_CR233","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1523\/JNEUROSCI.22-01-00038.2002","volume":"22","author":"O Touzani","year":"2002","unstructured":"Touzani O, Boutin H, LeFeuvre R, Parker L, Miller A, Luheshi G, Rothwell N (2002) Interleukin-1 influences ischemic brain damage in the mouse independently of the interleukin-1 type I receptor. J Neurosci 22:38\u201343","journal-title":"J Neurosci"},{"key":"863_CR234","doi-asserted-by":"publisher","first-page":"1366","DOI":"10.1016\/j.amjcard.2018.07.002","volume":"122","author":"CR Trankle","year":"2018","unstructured":"Trankle CR, Canada JM, Cei L, Abouzaki N, Oddi-Erdle C, Kadariya D, Christopher S, Viscusi M, Del Buono M, Kontos MC, Arena R, Van Tassell B, Abbate A (2018) Usefulness of canakinumab to improve exercise capacity in patients with long-term systolic heart failure and elevated C-reactive protein. Am J Cardiol 122:1366\u20131370. https:\/\/doi.org\/10.1016\/j.amjcard.2018.07.002","journal-title":"Am J Cardiol"},{"key":"863_CR235","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/j.bbrc.2009.07.152","volume":"388","author":"T van Es","year":"2009","unstructured":"van Es T, van Puijvelde GH, Ramos OH, Segers FM, Joosten LA, van den Berg WB, Michon IM, de Vos P, van Berkel TJ, Kuiper J (2009) Attenuated atherosclerosis upon IL-17R signaling disruption in LDLr deficient mice. Biochem Biophys Res Commun 388:261\u2013265. https:\/\/doi.org\/10.1016\/j.bbrc.2009.07.152","journal-title":"Biochem Biophys Res Commun"},{"key":"863_CR236","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1097\/FJC.0b013e3181c87e53","volume":"55","author":"BW Van Tassell","year":"2010","unstructured":"Van Tassell BW, Varma A, Salloum FN, Das A, Seropian IM, Toldo S, Smithson L, Hoke NN, Chau VQ, Robati R, Abbate A (2010) Interleukin-1 trap attenuates cardiac remodeling after experimental acute myocardial infarction in mice. J Cardiovasc Pharmacol 55:117\u2013122. https:\/\/doi.org\/10.1097\/FJC.0b013e3181c87e53","journal-title":"J Cardiovasc Pharmacol"},{"key":"863_CR237","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2020.252395","author":"J Venugopal","year":"2020","unstructured":"Venugopal J, Wang J, Mawri J, Guo C, Eitzman D (2020) Interleukin-1 receptor inhibition reduces stroke size in a murine model of sickle cell disease. Haematologica. https:\/\/doi.org\/10.3324\/haematol.2020.252395","journal-title":"Haematologica"},{"key":"863_CR238","doi-asserted-by":"publisher","first-page":"8692","DOI":"10.1523\/JNEUROSCI.23-25-08692.2003","volume":"23","author":"B Viviani","year":"2003","unstructured":"Viviani B, Bartesaghi S, Gardoni F, Vezzani A, Behrens MM, Bartfai T, Binaglia M, Corsini E, Di Luca M, Galli CL, Marinovich M (2003) Interleukin-1beta enhances NMDA receptor-mediated intracellular calcium increase through activation of the Src family of kinases. J Neurosci 23:8692\u20138700","journal-title":"J Neurosci"},{"key":"863_CR239","doi-asserted-by":"publisher","first-page":"2482","DOI":"10.1093\/eurheartj\/ehz008","volume":"40","author":"A Vromman","year":"2019","unstructured":"Vromman A, Ruvkun V, Shvartz E, Wojtkiewicz G, Santos Masson G, Tesmenitsky Y, Folco E, Gram H, Nahrendorf M, Swirski FK, Sukhova GK, Libby P (2019) Stage-dependent differential effects of interleukin-1 isoforms on experimental atherosclerosis. Eur Heart J 40:2482\u20132491. https:\/\/doi.org\/10.1093\/eurheartj\/ehz008","journal-title":"Eur Heart J"},{"key":"863_CR240","doi-asserted-by":"publisher","first-page":"9558","DOI":"10.1074\/jbc.270.16.9558","volume":"270","author":"P Wang","year":"1995","unstructured":"Wang P, Wu P, Siegel MI, Egan RW, Billah MM (1995) Interleukin (IL)-10 inhibits nuclear factor kappa B (NF kappa B) activation in human monocytes. IL-10 and IL-4 suppress cytokine synthesis by different mechanisms. J Biol Chem 270:9558\u20139563. https:\/\/doi.org\/10.1074\/jbc.270.16.9558","journal-title":"J Biol Chem"},{"key":"863_CR241","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/0021-9150(94)05503-b","volume":"115","author":"X Wang","year":"1995","unstructured":"Wang X, Feuerstein GZ, Gu JL, Lysko PG, Yue TL (1995) Interleukin-1 beta induces expression of adhesion molecules in human vascular smooth muscle cells and enhances adhesion of leukocytes to smooth muscle cells. Atherosclerosis 115:89\u201398. https:\/\/doi.org\/10.1016\/0021-9150(94)05503-b","journal-title":"Atherosclerosis"},{"key":"863_CR242","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.117.008024","author":"X Wang","year":"2018","unstructured":"Wang X, Guo Z, Ding Z, Mehta JL (2018) Inflammation, autophagy, and apoptosis after myocardial infarction. J Am Heart Assoc. https:\/\/doi.org\/10.1161\/JAHA.117.008024","journal-title":"J Am Heart Assoc"},{"key":"863_CR243","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1016\/j.immuni.2019.03.007","volume":"50","author":"JW Williams","year":"2019","unstructured":"Williams JW, Huang LH, Randolph GJ (2019) Cytokine circuits in cardiovascular disease. Immunity 50:941\u2013954. https:\/\/doi.org\/10.1016\/j.immuni.2019.03.007","journal-title":"Immunity"},{"key":"863_CR244","doi-asserted-by":"publisher","first-page":"567","DOI":"10.4049\/jimmunol.172.1.567","volume":"172","author":"L Williams","year":"2004","unstructured":"Williams L, Bradley L, Smith A, Foxwell B (2004) Signal transducer and activator of transcription 3 is the dominant mediator of the anti-inflammatory effects of IL-10 in human macrophages. J Immunol 172:567\u2013576. https:\/\/doi.org\/10.4049\/jimmunol.172.1.567","journal-title":"J Immunol"},{"key":"863_CR245","doi-asserted-by":"publisher","first-page":"1376","DOI":"10.1038\/jcbfm.2013.100","volume":"33","author":"MG Works","year":"2013","unstructured":"Works MG, Koenig JB, Sapolsky RM (2013) Soluble TNF receptor 1-secreting ex vivo-derived dendritic cells reduce injury after stroke. J Cereb Blood Flow Metab 33:1376\u20131385. https:\/\/doi.org\/10.1038\/jcbfm.2013.100","journal-title":"J Cereb Blood Flow Metab"},{"key":"863_CR246","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/j.ymgme.2008.11.166","volume":"96","author":"N Xiao","year":"2009","unstructured":"Xiao N, Yin M, Zhang L, Qu X, Du H, Sun X, Mao L, Ren G, Zhang C, Geng Y, An L, Pan J (2009) Tumor necrosis factor-alpha deficiency retards early fatty-streak lesion by influencing the expression of inflammatory factors in apoE-null mice. Mol Genet Metab 96:239\u2013244. https:\/\/doi.org\/10.1016\/j.ymgme.2008.11.166","journal-title":"Mol Genet Metab"},{"key":"863_CR247","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1111\/j.1471-4159.2005.03227.x","volume":"94","author":"T Yamashita","year":"2005","unstructured":"Yamashita T, Sawamoto K, Suzuki S, Suzuki N, Adachi K, Kawase T, Mihara M, Ohsugi Y, Abe K, Okano H (2005) Blockade of interleukin-6 signaling aggravates ischemic cerebral damage in mice: possible involvement of Stat3 activation in the protection of neurons. J Neurochem 94:459\u2013468. https:\/\/doi.org\/10.1111\/j.1471-4159.2005.03227.x","journal-title":"J Neurochem"},{"key":"863_CR248","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1161\/CIRCRESAHA.108.173963","volume":"103","author":"G Yan","year":"2008","unstructured":"Yan G, You B, Chen SP, Liao JK, Sun J (2008) Tumor necrosis factor-alpha downregulates endothelial nitric oxide synthase mRNA stability via translation elongation factor 1-alpha 1. Circ Res 103:591\u2013597. https:\/\/doi.org\/10.1161\/CIRCRESAHA.108.173963","journal-title":"Circ Res"},{"key":"863_CR249","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1161\/01.cir.101.9.1019","volume":"101","author":"Z Yang","year":"2000","unstructured":"Yang Z, Zingarelli B, Szabo C (2000) Crucial role of endogenous interleukin-10 production in myocardial ischemia\/reperfusion injury. Circulation 101:1019\u20131026. https:\/\/doi.org\/10.1161\/01.cir.101.9.1019","journal-title":"Circulation"},{"key":"863_CR250","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1097\/01.fjc.0000151930.12026.b7","volume":"45","author":"X Yu","year":"2005","unstructured":"Yu X, Patterson E, Huang S, Garrett MW, Kem DC (2005) Tumor necrosis factor alpha, rapid ventricular tachyarrhythmias, and infarct size in canine models of myocardial infarction. J Cardiovasc Pharmacol 45:153\u2013159. https:\/\/doi.org\/10.1097\/01.fjc.0000151930.12026.b7","journal-title":"J Cardiovasc Pharmacol"},{"key":"863_CR251","doi-asserted-by":"publisher","first-page":"1164","DOI":"10.1161\/ATVBAHA.109.187146","volume":"29","author":"H Zhang","year":"2009","unstructured":"Zhang H, Zhang J, Ungvari Z, Zhang C (2009) Resveratrol improves endothelial function: role of TNF{alpha} and vascular oxidative stress. Arterioscler Thromb Vasc Biol 29:1164\u20131171. https:\/\/doi.org\/10.1161\/ATVBAHA.109.187146","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"863_CR252","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1161\/ATVBAHA.119.312287","volume":"40","author":"TX Zhao","year":"2020","unstructured":"Zhao TX, Newland SA, Mallat Z (2020) 2019 ATVB plenary lecture: interleukin-2 therapy in cardiovascular disease: the potential to regulate innate and adaptive immunity. Arterioscler Thromb Vasc Biol 40:853\u2013864. https:\/\/doi.org\/10.1161\/ATVBAHA.119.312287","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"863_CR253","doi-asserted-by":"publisher","first-page":"11281","DOI":"10.1523\/JNEUROSCI.1685-15.2015","volume":"35","author":"X Zhao","year":"2015","unstructured":"Zhao X, Wang H, Sun G, Zhang J, Edwards NJ, Aronowski J (2015) Neuronal interleukin-4 as a modulator of microglial pathways and ischemic brain damage. J Neurosci 35:11281\u201311291. https:\/\/doi.org\/10.1523\/JNEUROSCI.1685-15.2015","journal-title":"J Neurosci"},{"key":"863_CR254","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.biopha.2018.12.031","volume":"111","author":"J Zhu","year":"2019","unstructured":"Zhu J, Huang J, Dai D, Wang X, Gao J, Han W, Zhang R (2019) Recombinant human interleukin-1 receptor antagonist treatment protects rats from myocardial ischemia-reperfusion injury. Biomed Pharmacother 111:1\u20135. https:\/\/doi.org\/10.1016\/j.biopha.2018.12.031","journal-title":"Biomed Pharmacother"}],"container-title":["Basic Research in Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00395-021-00863-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00395-021-00863-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00395-021-00863-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,24]],"date-time":"2023-10-24T01:25:17Z","timestamp":1698110717000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00395-021-00863-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,26]]},"references-count":254,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["863"],"URL":"https:\/\/doi.org\/10.1007\/s00395-021-00863-x","relation":{},"ISSN":["0300-8428","1435-1803"],"issn-type":[{"value":"0300-8428","type":"print"},{"value":"1435-1803","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,3,26]]},"assertion":[{"value":"3 February 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 March 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 March 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"LL, and GGC are coinventors on the International Patent (WO\/2020\/226993) filed in April 2020 and relating to the use of antibodies which specifically bind IL-1\u03b1 to reduce various sequelae of ischemia\u2013reperfusion injury to the central nervous system. The other authors report no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"23"}}